Articles
All (127)
SCI-E, SSCI, AHCI (71)
SCI-E, SSCI, AHCI, ESCI (86)
ESCI (12)
Scopus (89)
TRDizin (26)
Other Publications (25)
2026
20261. [ 11C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myeloma
Özkan E., Demir B., Cengiz Seval G., Araz M., Soydal Ç., Mesci İ., et al.
ANNALS OF NUCLEAR MEDICINE , vol.1, no.1, pp.1-11, 2026 (SCI-Expanded, Scopus)
2025
20252. Classical and endogen type of coronary microvascular dysfunction and potential association with cardiovascular events in a cardiometabolic disease population.
Mikhail S., Ozkan E., Valenta I., Parihar A. S., Jain S., Schindler T. H.
The international journal of cardiovascular imaging
, 2025 (SCI-Expanded, Scopus)
2025
20253. Prediction of [177Lu]Lu-PSMA-617 treatment response with [68Ga]Ga-PSMA-11 PET-derived variables and correlation of the overall survival with serum PSA and PSMA PET-based response criteria.
Ozkan E., Demir B., Soydal Ç., Araz M., Dursun E., Kucuk N. Ö., et al.
Revista espanola de medicina nuclear e imagen molecular
, pp.500208, 2025 (Peer-Reviewed Journal)
2025
20254. Coronary vasodilator capacity in obesity and morbid obesity - divergent flow responses with left ventricular hypertrophy.
Ozkan E., Dai L., Dehdashti F., Liu K., Schindler T. H.
International journal of cardiology. Heart & vasculature
, vol.60, pp.101785, 2025 (ESCI, Scopus)
2025
20255. Thoracic metabolic tumor volume predicts survival in advanced lung adenocarcinoma: A PET/computed tomography-based cohort study
Sahin A. M., ŞEN E., ÖZKAN E., Dursun E., SAK S.
Nuclear Medicine Communications
, vol.46, no.7, pp.629-635, 2025 (SCI-Expanded, Scopus)
2025
20256. Granulomatous Inflammation of Liver Mimicking Malignancy on 68Ga-FAPI PET/CT
ARAZ M., Dursun E., Mesci I., KONCA C., SOYDAL Ç., ÖZKAN E., et al.
CLINICAL NUCLEAR MEDICINE
, vol.50, no.7, 2025 (SCI-Expanded, Scopus)
2025
20257. Homogeneous reduction of 15O-water and PET-determined myocardial flow reserve as a reflection of coronary microvascular dysfunction?
Schindler T. H., Ozkan E., Valenta I.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING
, vol.26, no.7, pp.1128-1129, 2025 (SCI-Expanded, Scopus)
2025
20258. Diagnostic performance of fluorine-18-fluorodeoxyglucose PET/MRI for detection of disease recurrence in differentiated thyroid cancer: a compartment-based analysis
Özkan E., Ünal S., Akkuş P., Peker E., Araz M., Dursun E., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.46, no.3, pp.230-238, 2025 (SCI-Expanded, Scopus)
2025
20259. Mild basal interventricular inflammation as a predictor of ventricular arrhythmia?
Schindler T. H., Eslambolchi A., Ozkan E.
INTERNATIONAL JOURNAL OF CARDIOLOGY
, vol.419, 2025 (SCI-Expanded, Scopus)
2025
202510. Large Vessel Vasculitis and PET
ERTÜRK S. A., ÖZKAN E.
Turkiye Klinikleri Nuclear Medicine , 2025 (Peer-Reviewed Journal)
2024
202411. PET/MR Imagıng in Head and Neck Cancers
DURSUN E., ÖZKAN E.
NUCLEAR MEDICINE SEMINARS , vol.10, 2024 (Peer-Reviewed Journal)
2024
202412. A Case of Diffuse Infiltrative Hepatocellular Carcinoma with Marked Response to Sorafenib Treatment Evidenced by (18)F-FDG PET/MRI.
Özkan E., Demir B., Kuru Öz D., Ürün Y., Küçük N. Ö.
Molecular imaging and radionuclide therapy
, vol.33, no.3, pp.193-195, 2024 (ESCI, TRDizin)
2024
202413. PET/MRI in Urogenital System Tumors: How Helpful is it?
Erden G. A., Kuru Öz D., Özkan E., Küçük N. Ö.
Türk Radyoloji Seminerleri , vol.12, no.2, pp.362-387, 2024 (Peer-Reviewed Journal)
2024
202414. Hybrid Positron Emission Tomography and Magnetic Resonance Imaging Guided Microsurgical Management of Glial Tumors: Case Series and Review of the Literature
ÇAĞLAR Y. Ş., Buyuktepe M., Sayaci E. Y., DOĞAN İ., BOZKURT M., PEKER E., et al.
DIAGNOSTICS
, vol.14, no.14, 2024 (SCI-Expanded, Scopus)
2024
202415. Correlates of markers of dyssynchrony in patients with STEMI and multivessel disease: an analysis from the IAEA SPECT STEMI trial.
Peix A., Jimenez-Heffernan A., Devasenapathy N., Sobic-Saranovic D., Vitola J., Giubbini R., et al.
Nuclear medicine communications
, 2024 (SCI-Expanded, Scopus)
2024
202416. Procedure Guideline with F-18 FDG PET/CT in Large Vessel Vasculitis Büyük Damar Vaskülitlerinde F-18 FDG PET/BT ile Görüntüleme Kılavuzu
ERTÜRK S. A., ÖZKAN E., DEMİR H., Çağlıyan F., ÖZDEMİR S., Karaçavuş S., et al.
Nuclear Medicine Seminars
, vol.10, no.1, pp.104-116, 2024 (Scopus)
2024
202417. Posterior cingulate cortex hyperactivity in conversion disorder: a PET/MRI study
TATLI S. Z., ARAZ M., ÖZKAN E., PEKER E., Erden M., ŞENTÜRK CANKORUR V.
Frontiers in Psychiatry
, vol.15, 2024 (SCI-Expanded, SSCI, Scopus)
2024
202418. Myocardial Perfusion PET Procedure Guideline Miyokardiyal Perfüzyon PET/BT Uygulama Kılavuzu
Karaçavuş S., Yalçın H., ÖZKAN E., DEMİR H., Çağlıyan F., ÖZDEMİR S., et al.
Nuclear Medicine Seminars
, vol.10, no.1, pp.117-140, 2024 (Scopus)
2024
202419. Dynamic Radionuclide Myocardial Perfusion Imaging (SPECT and PET) Dinamik Miyokardiyal Perfüzyon Radyonüklit Görüntüleme (SPECT ve PET)
Şimşek D. H., ÖZKAN E.
Nuclear Medicine Seminars
, vol.10, no.1, pp.42-61, 2024 (Scopus)
2024
202420. Procedure Guideline for Scintigraphic Imaging in Cardiac Transthyretin Amyloidosis Kardiyak Transtiretin Tip Amiloidoz Değerlendirilmesinde Sintigrafik Görüntüleme Kılavuzu
ÖZDEMİR E., COŞKUN N., Altun G. D., DEMİR H., ÖZDEMİR S., Çağlıyan F., et al.
Nuclear Medicine Seminars
, vol.10, no.1, pp.90-103, 2024 (Scopus)
2023
202321. PSMA Targeted Ligands in Imaging and Theranostics for Prostate Cancer
Sen B., ÖZKAN E., KÜÇÜK N. Ö.
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
, no.4, pp.129-137, 2023 (ESCI, TRDizin)
2023
202322. Demonstration of therapy response to radioembolization with 90Y resin microspheres on 68Ga-PSMA PET/MRI in a patient with hepatocellular carcinoma
Özkan E., Demir B., Kuru Öz D., Soydal Ç., Dursun E., Çelebioğlu E. C., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.51, no.1, pp.316-317, 2023 (SCI-Expanded, Scopus)
2023
202323. A Rare Case of "Periportal Cuffing" as an Incidental Finding on (18)F-FDG PET/CT.
Demir B., Özkan E., Kaynak Şahap S., Sütçü G., Tuna Kırsaçlıoğlu C., Soydal Ç., et al.
Molecular imaging and radionuclide therapy
, vol.32, no.3, pp.252-254, 2023 (ESCI, Scopus, TRDizin)
2023
202324. Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial
Karthikeyan G., Peix A., Devasenapathy N., Jimenez-Heffernan A., Haque S., Rodella C., et al.
JOURNAL OF NUCLEAR CARDIOLOGY
, vol.30, no.3, pp.1091-1102, 2023 (SCI-Expanded, Scopus)
2023
202325. Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective study
Akkus Gunduz P., ÖZKAN E., KURU ÖZ D., SOYDAL Ç., ARAZ M., ERDEN G. A., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.44, no.2, pp.150-160, 2023 (SCI-Expanded, Scopus)
2022
202226. Can Serum Thyroglobulin Levels Help to Identify the Involved Neck Compartment of Differentiated Thyroid Carcinoma?
Bahcecioglu A. B., Ozkan E., Araz M., Elhan A. H., Erdogan M. F.
HORMONE AND METABOLIC RESEARCH
, vol.54, no.10, pp.658-663, 2022 (SCI-Expanded, Scopus)
2022
202227. A Rare Pitfall in Bone Mineral Densitometry Gaucher Disease
ARAZ M., SÜTÇÜ G., Surucu Kara L., Eminoglu T., ÖZKAN E.
CLINICAL NUCLEAR MEDICINE
, vol.47, no.8, 2022 (SCI-Expanded, Scopus)
2022
202228. Elevated Angiogenic Factor Levels After Transarterial Radioembolization for Colorectal Cancer Liver Metastases May Predict a Poor Prognosis
Soydal Ç., Araz M., Durmaz M., Özkan E., Ergüder B. İ., Küçük N. Ö., et al.
Molecular Imaging and Radionuclide Therapy
, vol.31, no.2, pp.114-122, 2022 (Scopus, TRDizin)
2022
202229. Combined clinical and specific positron emission tomography/computed tomography-based radiomic features and machine-learning model in prediction of thymoma risk groups
ÖZKAN E., ORHAN K., SOYDAL Ç., KAHYA Y., Seckin Tunc S., ÇELİK Ö., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.43, no.5, pp.529-539, 2022 (SCI-Expanded, Scopus)
2022
202230. Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer
Araz M., Soydal Ç., Özkan E., Sen E., Nak D., Kucuk O. N., et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.66, no.1, pp.61-66, 2022 (SCI-Expanded, Scopus)
2022
202231. Correlation of cancer status and brown adipose tissue activity on 18F-flourodeoxyglucose positron emission tomography/computed tomography
ARAZ M., GÜLPINAR B., GÜNDÜZ P., ÖZKAN E., ŞAHİN M.
Turkish Journal of Clinics and Laboratory
, vol.13, pp.52-58, 2022 (TRDizin)
2022
202232. Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?
Araz M., Soydal Ç., Gündüz P., Kırmızı B. A., Bakırarar B., Sak S., et al.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
, vol.31, no.1, pp.49-56, 2022 (ESCI, Scopus, TRDizin)
2022
202233. Myocardial perfusion SPECT findings in postCOVID period
Araz M., Soydal Ç., Sütçü G., Demir B., Özkan E.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.49, no.3, pp.889-894, 2022 (SCI-Expanded, Scopus)
2022
202234. Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma
Araz M., Özkan E., Gündüz P., Soydal Ç., Küçük N. Ö., Kır K. M.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
, vol.37, pp.56-62, 2022 (SCI-Expanded, Scopus)
2022
202235. Determination of Gastrointestinal System Bleeding Site and Imaging of Meckel\u2019s Diverticulum
DURSUN E., ÖZKAN E.
NUCLEAR MEDICINE SEMINARS , vol.8, 2022 (Peer-Reviewed Journal)
2021
202136. Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer
Soydal Ç., Araz M., Ürün Y., Nak D., Özkan E., Küçük N. Ö.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.65, no.3, pp.282-286, 2021 (SCI-Expanded, Scopus)
2021
202137. RECOMBINANT HUMAN THYROTROPIN VERSUS THYROID HORMONE WITHDRAWAL IN DIFFERENTIATED THYROID CARCINOMA FOLLOW-UP: A SINGLE CENTER EXPERIENCE
ŞAHİN M., AYDOĞAN B., ÖZKAN E., EMRAL R., GÜLLÜ S., ERDOĞAN M. F., et al.
ACTA ENDOCRINOLOGICA-BUCHAREST
, vol.17, no.3, 2021 (SCI-Expanded, Scopus)
2021
202138. Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters
Araz M., Soydal Ç., Özkan E., Akkus P., Nak D., Küçük N. Ö., et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
, vol.36, no.5, pp.425-432, 2021 (SCI-Expanded, Scopus)
2021
202139. The Role of Nuclear Medicine in the Diagnosis of NETs
Özkan E., Araz M.
Nuclear Medicine Seminars
, vol.7, 2021 (Peer-Reviewed Journal)
2021
202140. Use of Recombinant TSH in the Treatment and Monitoring of Well-Differentiated Thyroid Cancers
Özkan E., Araz M.
Nuclear Medicine Seminars
, vol.7, 2021 (Peer-Reviewed Journal)
2021
202141. A Rare Extramedullary Presentation of Multiple Myeloma: Paraspinal Muscle Involvement Revealed by FDG PET/CT
Özkan E., Araz M., Cengiz Seval G., Nak D., Beksaç M.
TURKISH JOURNAL OF HEMATOLOGY
, vol.38, no.1, pp.69-71, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202142. The prognostic value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters in patients with malignant pleural mesothelioma
YENİGÜN B. M., KAHYA Y., SOYDAL Ç., Tutkun N. A., KOCAMAN G., KOÇAK E. M., et al.
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
, vol.29, no.1, pp.93-101, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202043. Predictor of Ga-68 PSMA PET/CT positivity in patients with prostate cancer
Soydal Ç., Ürün Y., Süer E., Nak D., Özkan E., Küçük N. Ö.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.64, no.2, pp.226-230, 2020 (SCI-Expanded, Scopus)
2020
202044. Incidental F-18-Fluorocholine Uptake in an Esophageal Diverticulum F-18-FCH in an Esophageal Diverticulum
Araz M., Cinel M., Soydal Ç., Özkan E., Küçük N. Ö.
CLINICAL NUCLEAR MEDICINE
, vol.45, no.4, 2020 (SCI-Expanded, Scopus)
2020
202045. An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT
Araz M., Soydal Ç., Ozturk C., Özkan E., Demirer T.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.47, no.1, pp.218-219, 2020 (SCI-Expanded, Scopus)
2020
202046. First Experience of C-11-Methionine PET in Multiple Myeloma in Turkey
Ozkan E., Cengiz Seval G., Araz M., Kucuk N. Ö., Beksaç M.
TURKISH JOURNAL OF HEMATOLOGY
, vol.39, no.1, pp.66-67, 2020 (SCI-Expanded, Scopus, TRDizin)
2019
201947. F-18-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value
Soydal Ç., Araz M., Ürün Y., Gülpınar B., Nak D., Özkan E., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.40, no.12, pp.1268-1274, 2019 (SCI-Expanded, Scopus)
2019
201948. Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma
Soydal Ç., Nak D., Araz M., Akkus P., Ürün Y., Özkan E., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.40, no.12, pp.1243-1249, 2019 (SCI-Expanded, Scopus)
2019
201949. PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma
CENGİZ SEVAL G., ÖZKAN E., BEKSAÇ M.
PET CLINICS
, vol.14, no.3, pp.369-382, 2019 (ESCI, Scopus)
2019
201950. Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma
SOYDAL Ç., ÖZKAN E., Nak D., ELHAN A. H., KÜÇÜK N. Ö., KIR K. M.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
, vol.28, no.2, pp.69-75, 2019 (ESCI, Scopus, TRDizin)
2019
201951. Evaluation of Chemokine Receptor-4 Expression by 68Ga-Pentixafor PET/CT in Patients with Multiple Myeloma
ÖZKAN E., SOYDAL Ç., Sahin U., BEKSAÇ M., Ozturk C., CİVRİZ BOZDAĞ S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.29, no.4, pp.210-218, 2019 (SCI-Expanded, Scopus, TRDizin)
2018
201852. The efficacy of fluorine-18-choline PET/CT in comparison with Tc-99m-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism
Araz M., Soydal Ç., Özkan E., Kır K. M., İbiş E., Güllü S., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.39, no.11, pp.989-994, 2018 (SCI-Expanded, Scopus)
2018
201853. Targeted Minimally Invasive Parathyroidectomy for Ectopic Aortopulmonary Adenoma Under Gamma Probe Guidance
Ergi D. G., KEPENEKCİ BAYRAM İ., BARAN Ç., ÖZKAN E., İNAN M. B., AKAR A. R.
INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY
, vol.13, no.6, pp.451-454, 2018 (ESCI, Scopus)
2018
201854. Relation of 18F-FDG PET/CT Positivity with Tumor Cytopathology, Galectin-3, PTEN, Ki-67 and NIS Expressions in Thyroid Nodules
Cakmak G., Aydogan B. I., CANSIZ ERSÖZ C., ÖZKAN E., SAK S., GÜLLÜ S.
TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
, vol.22, no.3, pp.176-182, 2018 (ESCI, Scopus, TRDizin)
2018
201855. Karaciğer tümörlerinde intraarteriyel Y-90 mikroküre tedavi uygulamaları, yan etkiler ve hasta takibi
ÖZKAN E., SOYDAL Ç.
Türkiye Klinikleri , pp.23-25, 2018 (TRDizin)
2017
201756. Dynamic risk stratification for predicting the recurrence in differentiated thyroid cancer
ÖZKAN E., SOYDAL Ç., Nak D., KÜÇÜK N. Ö., KIR K. M.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.38, no.12, pp.1055-1059, 2017 (SCI-Expanded, Scopus)
2017
201757. Sentinel Lymph Node Biopsy for Gastrointestinal Cancers
BİRBEN B., ÖZKAN E., ZÜLFİKAROĞLU B., SOYDAL Ç., TEZ M., KÜÇÜK N. Ö.
Nükleer Tıp Seminerleri
, vol.3, no.2, pp.129-139, 2017 (Peer-Reviewed Journal)
2017
201758. Comparison of 18F-FDG PET/CT and ceCT results in the assesment of RCC recurrence
ÖZKAN E., ARAZ M., SOYDAL Ç., ARAS G.
Studies on Stem Cells Research and Therapy , vol.3, no.1, pp.1-5, 2017 (Peer-Reviewed Journal)
2017
201759. Ga-68 PSMA Accumulation in Hepatocellular Carcinoma
SOYDAL Ç., ALKAN A., ÖZKAN E., DEMİRKAZIK A., KÜÇÜK N. Ö.
Journal of Gastroenterology, Pancreatology Liver Disorders
, vol.4, no.2, pp.1, 2017 (Peer-Reviewed Journal)
2017
201760. Functional compared to anatomical imaging in the initial evaluation of patients with suspected coronary artery disease: An international, multi-center, randomized controlled trial (IAEA-SPECT/CTA study)
Karthikeyan G., Salobir B. G., Jug B., Devasenapathy N., Alexanderson E., Vitola J., et al.
JOURNAL OF NUCLEAR CARDIOLOGY
, vol.24, no.2, pp.507-517, 2017 (SCI-Expanded, Scopus)
2017
201761. Is Routine Diagnostic Radioiodine Whole-Body Scintigraphy Needed in Patients who Received Ablative doses of Radioiodine for Differentiated Thyroid Carcinoma?
SOYDAL Ç., ÖZKAN E., NAK D., KÜÇÜK N. Ö., KIR K. M.
International Journal of Nuclear Medicine Research , vol.4, no.1, pp.1-5, 2017 (Peer-Reviewed Journal)
2017
201762. Pediatrik Olgularda Tiroid Kanserleri
ÖZKAN E., SOYDAL Ç.
Turkiye Klinikleri J Nucl Med-Special Topics
, vol.3, no.1, pp.71-76, 2017 (TRDizin)
2017
201763. Widespread Metastatic Involvement in a Patient with Merkel Cell Carcinoma on 68Ga-DOTATATE PET/CT: Case Report
ÖZKAN E., SOYDAL Ç., ALKAN A., UTKAN G.
Turkiye Klinikleri Journal of Case Reports , vol.25, no.1, pp.10-13, 2017 (TRDizin)
2017
201764. Comparison of 18F-FDG PET/CT and ceCT results in the assessment of RCC recurrence
ÖZKAN E., ARAZ M., SOYDAL Ç., ARAS G.
Studies on Stem Cells Research and Thearpy , vol.3, no.1, pp.1-5, 2017 (Peer-Reviewed Journal)
2017
201765. May preablative thyroglobulin level be a prognostic indicator for papillary thyroid cancer?
ÖZKAN E., SOYDAL Ç., ARAZ M., GENÇ Y., KÜÇÜK N. Ö.
Clinical and Medical Investigations
, vol.2, no.1, pp.1-16, 2017 (Peer-Reviewed Journal)
2016
201666. Demonstration of Response to Androgen Deprivation Therapy by Ga-68-PSMA PET/CT
SOYDAL Ç., ÖZKAN E., Kaya B., KÜÇÜK N. Ö.
CLINICAL NUCLEAR MEDICINE
, vol.41, no.10, pp.794-796, 2016 (SCI-Expanded, Scopus)
2016
201667. Challenging Management of Neuroendocrine Tumor With Hepatic Metastasis and Carcinoid Heart Disease in a Child
Yesil S., Tanyildiz H. G., Bozkurt C., Sahin G., Ozgur S., ÖZKAN E., et al.
PEDIATRIC BLOOD & CANCER
, vol.63, no.8, pp.1499-1500, 2016 (SCI-Expanded, Scopus)
2016
201668. Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor
ÖZKAN E., SOYDAL Ç., Semirgin S. U., Yapici O., ATMACA A., Demirag G.
CLINICAL NUCLEAR MEDICINE
, vol.41, no.7, pp.561-563, 2016 (SCI-Expanded, Scopus)
2016
201669. Excision of mediastinal parathyroid adenoma under the guidance of gamma probe
Sakalli M. A., ÖZKAN M., ÖZKAN E., Akal M.
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
, vol.24, no.3, pp.585-588, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201670. Clinical significance of thyroid incidentalomas identified by F-18-FDG PET/CT: correlation of ultrasonograpy findings with cytology results
DEMİR Ö., Kose N., ÖZKAN E., ÜNLÜTÜRK U., Aras G., ERDOĞAN M. F.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.37, no.7, pp.715-720, 2016 (SCI-Expanded, Scopus)
2016
201671. Widespread Metastatic Prostate Carcinoma Shown by 68Ga-PSMA PET/CT
SOYDAL Ç., ÖZKAN E., Yerlikaya H., UTKAN G., KÜÇÜK N. Ö.
CLINICAL NUCLEAR MEDICINE
, vol.41, no.6, 2016 (SCI-Expanded, Scopus)
2016
201672. Assessment of Gastric Emptying in Patients with Autoimmune Gastritis
Kalkan C., Soykan I., SOYDAL Ç., ÖZKAN E., Kalkan E.
DIGESTIVE DISEASES AND SCIENCES
, vol.61, no.6, pp.1597-1602, 2016 (SCI-Expanded, Scopus)
2016
201673. Relationships between autonomic nerve function and gastric emptying in patients with autoimmune gastritis
Kalkan C., SOYDAL Ç., ÖZKAN E., Maden A., Soykan I.
CLINICAL AUTONOMIC RESEARCH
, vol.26, no.3, pp.189-196, 2016 (SCI-Expanded, Scopus)
2016
201674. Can Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Be Used As a Useful Method to Evaluate the Treatment Response to Neoadjuvant Therapy Combined With Sorafenib and Anti-VEGF in Children Diagnosed With Metastatical Bone Sarcoma?
TAÇYILDIZ N., Tanyildiz H. G., DİNÇASLAN H., Yavuz G., ÜNAL E., ÖZKAN E., et al.
IRANIAN JOURNAL OF PEDIATRICS
, vol.26, no.2, 2016 (SCI-Expanded, Scopus)
2016
201675. Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer
SOYDAL Ç., ÖZKAN E., AKYÜREK S., KÜÇÜK N. Ö.
CLINICAL NUCLEAR MEDICINE
, vol.41, no.2, pp.159-160, 2016 (SCI-Expanded, Scopus)
2016
201676. Effect of the application of prophylactic central compartment lymph node dissection on radioiodine ablation doses in patients with papillary thyroid carcinoma
SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.46, no.4, pp.1078-1082, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201677. Ga 68 DOTATATE positron emission tomography computed tomography findings in patients with neuroendocrine tumor suspicion
SOYDAL Ç., ÖZKAN E., BALİ ATAŞ E., KÜÇÜK N. Ö., KIR K. M.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.69, no.1, pp.7-10, 2016 (TRDizin)
2016
201678. Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis
ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
International Journal of Nuclear Medicine Research , vol.3, 2016 (Peer-Reviewed Journal)
2016
201679. Impact of 18F FDG PET Ct for detecting primarp tumor focus in patients with histopathologically proven metastasis
ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
International Journal of Nuclear Medicine Research , vol.3, pp.56-62, 2016 (Peer-Reviewed Journal)
2016
201680. The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of response to fixed-dose peptide receptor radionuclide therapy with Lu-177 DOTATATE
SOYDAL Ç., Peker A., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.46, no.2, pp.409-413, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201581. The Utility of Intraoperative Handheld Gamma Camera for Detection of Sentinel Lymph Nodes in Melanoma
ÖZKAN E., EROĞLU A.
NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.49, no.4, pp.318-320, 2015 (ESCI, Scopus)
2015
201582. F-18-NaF Positive Bone Metastases of Non F-18-FDG Avid Mucinous Gastric Cancer
Soydal Ç., Özkan E., Küçük N. Ö., Kır K. M.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
, vol.24, no.3, pp.132-134, 2015 (ESCI, TRDizin)
2015
201583. Ga-68 DOTATATE Accumulation in Sarcoidosis
SOYDAL Ç., KÜÇÜK N. Ö., ÖZKAN E., ÖZDEMİR KUMBASAR Ö., KIR K. M.
International Journal of Nuclear Medicine Research , vol.2, no.2, pp.1-4, 2015 (Peer-Reviewed Journal)
2015
201584. Theranostics in Neuroendocrine Tumors
ÖZKAN E., SOYDAL Ç.
Nükleer Tıp Seminerleri , vol.1, no.2, pp.103-108, 2015 (Peer-Reviewed Journal)
2015
201585. Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy
SOYDAL Ç., Keskin O., KÜÇÜK N. Ö., ÖZKAN E., Bilgic S., İDİLMAN R., et al.
ANNALS OF NUCLEAR MEDICINE
, vol.29, no.5, pp.426-430, 2015 (SCI-Expanded, Scopus)
2015
201586. The Role of F-18-FDG PET/CT in the Primary Staging of Gastric Cancer
Filik M., KIR K. M., Aksel B., SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö., et al.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
, vol.24, no.1, pp.15-20, 2015 (ESCI, TRDizin)
2015
201587. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment
SOYDAL Ç., ARAZ M., ÖZKAN E., Arslantas E., KÜÇÜK N. Ö., Aras G.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.36, no.2, pp.109-113, 2015 (SCI-Expanded, Scopus)
2015
201588. Fluorine 18 Fluorodeoxyglucose positron emission tomography computed tomography in the detection of ovarian cancer recurrence in patients with elevated serum Ca 125 levels and whether the recurrence appears by conventional imaging
KÖROĞLU R., ÖZKAN E., SOYDAL Ç., İBİŞ E.
International Journal of Nuclear Medicine Research
, vol.2, pp.1-6, 2015 (Peer-Reviewed Journal)
2015
201589. Nöroendokrin tümörlerde moleküler görüntüleme
ÖZKAN E., SOYDAL Ç.
Türkiye Klinikleri J Nucl Med-Special Topics , vol.1, no.1, pp.95-101, 2015 (Peer-Reviewed Journal)
2015
201590. Assessment of Sorafenib and AntiVEGF Combination Therapy Response which Added to Neoadjuvant Therapy in two Pediatric Metastatic Ewing Sarcoma Patients by Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography 18F PET Method It may Determine the Prognosis
TAÇYILDIZ N., TANYILDIZ G., SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö., YAVUZ L. G., et al.
Journal of Nuclear Medicine & Radiation Therapy
, vol.6, no.02, 2015 (Peer-Reviewed Journal)
2015
201591. The role of 18F FDG PET CT in the primary staging of gastric cancer
FİLİK M., KIR K. M., AKSEL B., SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö., et al.
Molecular Imaging and Radionuclide Therapy
, vol.24, no.1, pp.15-20, 2015 (TRDizin)
2014
201492. The Role of 18F-Flourodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) in Pelvic and Paraaortic Lymph Node Staging of Uterine Cervical Cancer
SOYDAL Ç., İBİŞ E., ORTAÇ F., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.
International Journal of Nuclear Medicine Research
, vol.1, no.1, pp.1-6, 2014 (Peer-Reviewed Journal)
2014
201493. Prognostic value of metabolic tumor volume measured by 18F FDG PET CT in esophageal cancer patients
SOYDAL Ç., YÜKSEL C., KÜÇÜK N. Ö., ÖKTEN İ., ÖZKAN E., DOĞANAY ERDOĞAN B.
Molecular Imaging and Radionuclide Therapy
, vol.23, no.1, pp.12-15, 2014 (TRDizin)
2014
201494. The role of 18F Flourodeoxyglucose 18F FDG positron emission tomography computed tomography PET CT in pelviv and paraaortic lymph node stageng of uterine cervical cancer
SOYDAL Ç., İBİŞ E., ORTAÇ F., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.
Internationl Journal of Nuclear Medicine Research
, vol.1, pp.1-6, 2014 (Peer-Reviewed Journal)
2013
201395. Correlation of F-18-FDG PET/CT Findings With Histopathological Results in Differentiated Thyroid Cancer Patients Who Have Increased Thyroglobulin or Antithyroglobulin Antibody Levels and Negative I-131 Whole-Body Scan Results
ÖZKAN E., Aras G., KÜÇÜK N. Ö.
CLINICAL NUCLEAR MEDICINE
, vol.38, no.5, pp.326-331, 2013 (SCI-Expanded, Scopus)
2013
201396. Evaluation of the Response to Selective Internal Radiation Therapy in Patients With Hepatocellular Cancer According to Pretreatment Tc-99m-MAA Uptake
KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., ÖZKAN E., Aras G.
CLINICAL NUCLEAR MEDICINE
, vol.38, no.4, pp.252-255, 2013 (SCI-Expanded, Scopus)
2013
201397. Hipertansif Hastalarda Tl 201 Myokard Perfüzyon Sintigrafisinde İzlenen Lateral Hipoperfüzyonun MIBI Non Gated ve Gated SPECT ile Değerlendirilmesi
KOCA G., İBİŞ E., KÜÇÜK N. Ö., ÖZKAN E., KULAK H., KOPARAL H., et al.
Medical Journal of Ankara Training and Research Hospital , vol.26, no.2, pp.73-81, 2013 (Peer-Reviewed Journal)
2013
201398. Positron emission tomography computed tamography in locally advanced breast cancer
ÖZKAN E.
Experimental Oncology
, vol.35, no.4, pp.253-257, 2013 (Scopus)
2012
201299. Intense Ga-68 Dotatate Uptake in Recurrent MTC Patient
SOYDAL Ç., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., DEMİRER T.
World Journal of Endocrine Surgery
, vol.4, no.3, pp.118-119, 2012 (Scopus)
2012
2012100. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study
ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.33, no.9, pp.990-994, 2012 (SCI-Expanded, Scopus)
2012
2012101. Unexpected F-18-FDG uptake in an ocular prosthesis
ÖZKAN E., ARAZ M., SOYDAL Ç., Aras G.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.39, no.9, pp.1517-1518, 2012 (SCI-Expanded, Scopus)
2012
2012102. The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels
ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G., İBİŞ E.
CLINICAL NUCLEAR MEDICINE
, vol.37, no.8, pp.755-758, 2012 (SCI-Expanded, Scopus)
2012
2012103. Detection of Intraluminal Tracheal Metastasis of Thyroid Papillary Carcinoma by F-18-FDG PET/CT
ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö., İBİŞ E.
CLINICAL NUCLEAR MEDICINE
, vol.37, no.6, 2012 (SCI-Expanded, Scopus)
2012
2012104. Can injection of pentagastrin stimulate the identification of metastases of medullary thyroid carcinoma by F-18-FDG PET/CT?
ERDOĞAN M. F., DEMİR Ö., ÖZKAN E., KÜÇÜK N. Ö.
HELLENIC JOURNAL OF NUCLEAR MEDICINE
, vol.15, no.2, pp.155-156, 2012 (SCI-Expanded, Scopus)
2012
2012105. The role of F-18-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels
ÖZKAN E., SOYDAL Ç., ARAZ M., KIR K. M., İBİŞ E.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.33, no.4, pp.395-402, 2012 (SCI-Expanded, Scopus)
2012
2012106. Intense ga-68 dotatate uptake in recurrent mtc patients
SOYDAL Ç., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., DEMİRER T.
WORLD JOURNAL OF ENDOCRINE SURGERY , vol.4, no.3, pp.118-119, 2012 (Scopus)
2012
2012107. Clinical Experience of F-18-FDG PET/CT in Soft Tissue and Osseous Sarcomas
ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.22, no.3, pp.163-169, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
2012108. Endometrial adenocarcinoma and colon cancer association: Positron emission tomography with an area preoperative diagnosis Endometrial adenokarsinoma ve kolon kanseri birlikteliǧi: Pozitron emisyon tomografisi ile preoperatif tani alan bir olgu
Tülek F., Kahraman K., TAŞKIN S., ÖZKAN E., Ortaç F.
Turk Jinekolojik Onkoloji Dergisi
, vol.15, no.3, pp.96-100, 2012 (Scopus)
2011
2011109. Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
ÖZKAN E., SOYDAL Ç., KÜÇÜK N. Ö., İBİŞ E., Erbay G.
Nuclear Medicine Communications
, vol.32, no.12, pp.1162-1168, 2011 (SCI-Expanded, Scopus)
2011
2011110. Differentiated thyroid carcinomas in childhood: clinicopathologic results of 26 patients
ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
, vol.24, no.9-10, pp.739-742, 2011 (SCI-Expanded, Scopus)
2011
2011111. Intra-Arterial Treatment with (90)Yttrium Microspheres in Treatment-Refractory and Unresectable Liver Metastases of Neuroendocrine Tumors and the Use of In-111-Octreotide Scintigraphy in the Evaluation of Treatment Response
Lacin S., ÖZ İ. İ., ÖZKAN E., KÜÇÜK N. Ö., Bilgic S.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
, vol.26, no.5, pp.631-637, 2011 (SCI-Expanded, Scopus)
2011
2011112. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors
KÜÇÜK N. Ö., SOYDAL Ç., Lacin S., ÖZKAN E., Bilgic S.
WORLD JOURNAL OF SURGICAL ONCOLOGY
, vol.9, 2011 (SCI-Expanded, Scopus)
2011
2011113. Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients
ÖZKAN E., Tokmak E., KÜÇÜK N. Ö.
ANNALS OF NUCLEAR MEDICINE
, vol.25, no.6, pp.425-431, 2011 (SCI-Expanded, Scopus)
2011
2011114. The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastriccancer: Comparison with spiral CT
ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö.
WORLD JOURNAL OF SURGICAL ONCOLOGY
, vol.9, 2011 (SCI-Expanded, Scopus)
2011
2011115. Assessment of immature teratoma by 18F-FDG PET/CT
ÖZKAN E., Yagci S., Dogan M., Lacin S., KÜÇÜK N. Ö., AKBULUT H.
European Journal of Radiology Extra
, vol.78, no.3, 2011 (Scopus)
2011
2011116. Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
ÖZKAN E., SOYDAL Ç., KÜÇÜK N. Ö., İBİŞ E., Erbay G.
JOURNAL OF NUCLEAR MEDICINE
, vol.52, 2011 (SCI-Expanded, Scopus)
2011
2011117. Differentiated thyroid corcinomas in childhood: clinicopathologic results of 26 patients
ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
Journal of Pediatric Endocrinology and Metabolism , vol.24, no.9-10, pp.739-742, 2011 (Peer-Reviewed Journal)
2011
2011118. Ocular involvement in mantlecell lymphoma detected by 18F FDG PET CT
ÖZKAN E., ÇAĞIL S., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
Molecular Imaging and Radionuclide Therapy , vol.20, no.1, pp.36-37, 2011 (Peer-Reviewed Journal)
2011
2011119. F18 FDG PET CT scanning in angiosarcoma report of two cases
TOKMAK E., ÖZKAN E., YAĞCI G. Ş., KIR K. M.
Molecular Imaging and Radionuclide Therapy
, vol.20, no.2, pp.63-66, 2011 (TRDizin)
2011
2011120. Ocular involvement in mantle cell lymphoma detected by F 18 FDG PET CT
Özkan E., Laçin S., Soydal Ç., Araz M., Küçük N. Ö.
Molecular Imaging and Radionuclide Therapy
, vol.20, no.1, pp.36-37, 2011 (TRDizin)
2009
2009121. Evaluation of Extrapulmonary Ga-67 Uptake in Sarcoidosis: A Retrospective Analysis
KÜÇÜK N. Ö., ÖZKAN E., Uzun B., ÇELİK G., ÖZDEMİR KUMBASAR Ö., Aras G.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, vol.29, no.2, pp.375-380, 2009 (SCI-Expanded, Scopus)
2009
2009122. Evaluation of extrapulmonary Ga-67 uptake in sarcoidosis: A retrospective analysis
KÜÇÜK N. Ö., ÖZKAN E., Uzun B., ÇELİK G., Kumbasar Ö., Aras G.
Turkiye Klinikleri Journal of Medical Sciences
, vol.29, no.2, pp.375-380, 2009 (SCI-Expanded, Scopus)
2008
2008123. Detection of thyroid plasmacytoma by F-18FDG PET/CT imaging
ÖZKAN E., Tokmak E., KIR K. M.
CLINICAL NUCLEAR MEDICINE
, vol.33, no.4, pp.292-293, 2008 (SCI-Expanded, Scopus)
2007
2007124. Uncommon extent involvement of sarcoidosis in F-18-FDG PET/CT
Kuecuek N. O., Oezkan E., Aras G.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.34, no.12, pp.2151, 2007 (SCI-Expanded, Scopus)
2007
2007125. Decreased Tc-99m sestamibi uptake in a sternal brown tumor indicating response to anti metabolic therapy for secondary hyperparathyroidism
ÖZKAN E., Arslan N., Arslanoglu A., Karacalioglu A. O.
CLINICAL NUCLEAR MEDICINE
, vol.32, no.8, pp.661-662, 2007 (SCI-Expanded, Scopus)
2003
2003126. Visualization of collaterals in Budd-Chiari syndrome with Tc-99m MDP bone scintigraphy and Tc-99m HMPAO-Labeled leukocyte scintigraphy
Kusuk N., ÖZKAN E., Aras G., KIR K. M.
CLINICAL NUCLEAR MEDICINE
, vol.28, no.3, pp.236-237, 2003 (SCI-Expanded, Scopus)
2001
2001127. Colonic visualization during renal scintigraphy secondary to ureterosigmoidostomy
ÖZKAN E., Ozlem N., Kucuk K., KIR K. M., Erbay G.
CLINICAL NUCLEAR MEDICINE
, vol.26, no.5, pp.477-478, 2001 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. PET-determined Myocardial Blood Flow and Left Ventricular Hypertrophy in Obesity
ÖZKAN E., KAN L., GHAZAL S., AZADEH E., FARROKH D., SCHINDLER T.
SNMMI 2025, 21 - 24 June 2025, (Full Text)
2025
20252. F-18 FES PET’in Metastatik Meme Kanserinde Östrojen Reseptör Heterojenitesinin Gösterilmesindeki Yeri
DURSUN E., ÖZKAN E., SOYDAL Ç., KÜÇÜK N. Ö., ARAZ M., DEMİR B., et al.
37.Ulusal Nükleer Tıp Kongresi, 9 - 13 April 2025, (Full Text)
2024
20243. The Value of fdg pet/ct for diagnosing metastic infections in staphylococcus aureus bacteremia
SARICAOĞLU E. M., GÜLTEN E., ÇINAR G., AKDEMİR İ., Hüseyinli T., Çakmak P., et al.
33rd International Congress of Antimicrobial Chemotherapy, 03 November 2024, (Full Text)
2024
20244. The value of fdg pet/ct for diagnosing metastatic infections in staphylococcus aureus bacterema
SARICAOĞLU E. M., GÜLTEN E., ÇINAR G., AKDEMİR İ., HÜSEYNLİ T., ÇAKMAK P., et al.
Journal of Antimicrobal Restistance, 23 October 2024, (Full Text)
2024
20245. Dual FES/FDG PET/CT imaging to predict therapy response in patients with estrogen receptor-positive recurrent or metastatic breast cancer: Preliminary Results
DURSUN E., ÖZKAN E., YAŞAR H. A., ARAZ M., AKSOY S., ÜRÜN Y., et al.
Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 October 2024, vol.51, pp.493-494, (Full Text)
2024
20246. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer
ARAZ M., SOYDAL Ç., DURSUN E., MESCİ İ., KONCA C., ÖZKAN E., et al.
Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 October 2024, vol.51, pp.17, (Full Text)
2024
20247. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer
ARAZ M., SOYDAL Ç., DURSUN E., Mesci İ., KONCA C., ÖZKAN E., et al.
Annual Congress of the European Association of Nuclear Medicine October 19–23, 2024 Hamburg, Germany, Hamburg, Germany, 19 October 2024, vol.51, pp.17, (Summary Text)
2024
20248. SKLEROZAN ANJIYOMATOID NODÜLER TRANSFORMASYON OLGUSU
Özdemir S., AKPINAR A., TEKE S., TUNA KIRSAÇLIOĞLU C., KULOĞLU Z., FİTOZ Ö. S., et al.
15. ULUSAL ÇOCUK GASTROENTEROLOJİ, HEPATOLOJİ ve BESLENME KONGRESİ, Turkey, 30 May 2024, (Summary Text)
2024
20249. FES-PET GÖRÜNTÜLEMESI ILE EVRESI VE TEDAVI PLANI DEĞIŞEN BIR MEME KANSERI OLGUSU
Ballı S., Dursun B., Özkan E., Dursun E., Azılı C., Bayar S., et al.
11. Türk Tıbbi Onkoloji Kongresi , Girne, Cyprus (Kktc), 24 - 28 April 2024, pp.182, (Full Text)
2024
202410. Sklrerozan anjimatodi noduler transformasyon olgusu
Özdemir S., Akpınar A., Teke S., TUNA KIRSAÇLIOĞLU C., KULOĞLU Z., FİTOZ Ö. S., et al.
15. Çocuk Gastroenteroloji Hepatoloji ve Beslenme Kongresi, Trabzon, Turkey, 30 May 2024, pp.176, (Full Text)
2024
202411. Lu-177 PSMA tedavisine yanıtın RECIP kriterleri ve PSA düzeyi ile değerlendirilmesi ve sağkalım ile korelasyonu
ÖZKAN E., DEMİR B., SOYDAL Ç., DURSUN E., ARAZ M., ÜRÜN Y., et al.
36.Ulusal Nükleer Tıp Kongresi, 8 - 12 May 2024, (Full Text)
2024
202412. İleri Evre Akciğer Adenokanserinde 18F-FDG PET/BT Parametrelerinin Prognoza Etkisi
Şahin A. M., Şen E., Özkan E., Dursun E.
Türk Toraks Derneği 27. Yıllık Kongresi, Girne, Cyprus (Kktc), 29 April - 03 May 2024, pp.168, (Full Text)
2024
202413. Hybrıd F18-FDG PET/MRI in endometrial cancer: staging accuracy, quantitative analysis, and imaging characteristics of histological subtypes
KURU ÖZ D., ARAZ M., Yılmazer Zorlu N. S., VARLI B., SOYDAL Ç., TAŞKIN S., et al.
European Congress of Radiology, ECR 2024, Austria, 28 February - 03 March 2024, (Full Text)
2023
202314. PRe-treatment 68Ga-PSMA PET/CT parameters could predict response to 177Lu-PSMA tretament and overall survival in metastatic castration resistant prostate carcinoma patients treated with 177Lu-PSMA
ÖZKAN E., DEMİR B., ÖZTÜRK M., ARAZ M., SOYDAL Ç., DURSUN B., et al.
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)
2023
202315. Comparison of C-11 methionine and F-18 FDG PET/CT findings in evaluation of multiple myeloma: first Turkey Experience
ÖZKAN E., DEMİR B., CENGİZ SEVAL G., ARAZ M., SOYDAL Ç., BEKSAÇ M., et al.
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)
2023
202316. Ischemia-guided vs routine non-culprit vessel percutaneous coronary intervention for patients with multi-vessel disease presenting with ST segment elevation myocardial infarction: the IAEA SPECT STEMI trial
Giammarile F., Karthikeyan G., Peix A., Devasenapathy N., Jimenez-Heffernan A., Haque S., et al.
55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON), Jodhpur, India, 16 - 19 November 2023, (Summary Text)
2023
202317. Multiple myelomada hastalık değerlendirilmesinde C-11 Metiyonin PET/BT deneyimi
ÖZKAN E., DEMİR B., CENGİZ SEVAL G., ARAZ M., SOYDAL Ç., BEKSAÇ M., et al.
35.Ulusal Nükleer Tıp Kongresi, 26 April 2023, (Full Text)
2023
202318. Multiple myelomada hastaık değerlendirilmesinde C-11 Metiyonin PET/BT deneyimi
ÖZKAN E., DEMİR B., CENGİZ SEVAL G., ARAZ M., SOYDAL Ç., BEKSAÇ M., et al.
35.Ulusal Nükleer Tıp Kongresi, 26 April 2023, (Full Text)
2022
202219. Endometrium kanserinde hibrid F-18-DG PET/MRG: evreleme başarısı, kantitatif değerlendirme, histolojik alt tiplerin görüntüleme özellikleri
KURU ÖZ D., ARAZ M., VARLI B., SOYDAL Ç., YAVUZ Z., TAŞKIN S., et al.
43.Ulusal Radyoloji Kongresi, 2022, 01 November 2022, (Summary Text)
2022
202220. RAI tedavisi sonrası I-131 tüm vücut taramada protez gözde radyoaktif iyot tutulumu.
ARAZ M., BALTACIOĞLU M. H., DURSUN E., DEMİR B., SOYDAL Ç., ÖZKAN E., et al.
34.Ulusal Nükleer Tıp Kongresi, Turkey, 27 March - 31 August 2022, (Full Text)
2022
202221. Evaluation of brain functions in conersion disordr with PET/MRI
TATLI S. Z., ÖZKAN E., ARAZ M., ERDEN M. İ., ŞENTÜRK CANKORUR V.
Abstracts of the 30th European Congress of Psychiatry, 04 June 2022, (Full Text)
2022
202222. DBBHL’Lİ Olguda Nadir Ekstranodal Tutulumlar
ARAZ M., GÜNDÜZ P., BALTACIOĞLU M. H., SÜTÇÜ G., ÖZKAVUKCU E., YÜKSEL M., et al.
34.Ulusal Nükleer Tıp Kongresi, 27 March 2022, vol.8, pp.157-158, (Summary Text)
2022
202223. Kardiyak Metastaz Saptanan Dil Kanseri Olgusunda F-18 FDG PET/BT ve MPS Bulguları
ARAZ M., BALTACIOĞLU M. H., GÜNDÜZ P., SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö.
34.Ulusal Nükleer Tıp Kongresi, 27 March 2022, vol.8, pp.137-138, (Summary Text)
2022
202224. F-18 FCH PET/BT ile Saptanan Tc-99m MIBI Negatif İntratimik Paratiroid Adenomu
ARAZ M., GÖRGÜNER F., KEPENEKCİ BAYRAM İ., KAYI CANGIR A., ÖZKAN E., KÜÇÜK N. Ö.
34.Ulusal Nükleer Tıp Kongresi, 27 March 2022, vol.8, pp.102, (Summary Text)
2021
202125. HCC: Neler değişti?
ÖZKAN E.
2.Girişimsel Onkoloji: Multidisipliner Tedavi Yaklaşımı Toplantısı, 2021, 17 December 2021
2021
202126. Kolorektal kanser karaciğer metastazlarında PET/MRG'nin katkısı: MRG ile karşılaştırma
KURU ÖZ D., GÜNDÜZ P., ÖZKAN E., ERDEN G. A.
42.Ulusal Radyoloji Kongresi, 2021, Turkey, 26 October 2021, pp.159-160, (Full Text)
2021
202127. Myocardial perfusion SPECT findings in postcovid period
ARAZ M., SÜTÇÜ G., DEMİR B., ÖZKAN E., SOYDAL Ç.
Annuals Congress of the European Association of Nuclear Medicine, 2021, 20 October 2021, vol.48, pp.184, (Full Text)
2021
202128. Added value of F18-FDG PET/MR imaging for detecting liver metastases in patients with colorectal cancer
GÜNDÜZ P., ÖZKAN E., KURU ÖZ D., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö., et al.
Annuals Congress of the European Association of Nuclear Medicine, 20 October 2021, vol.48, pp.184, (Full Text)
2021
202129. Radiomics analyses in 18F-FDG PET images of breast carcinoma to predict hormone receptor statut: histopathological correlational study
ARAZ M., SOYDAL Ç., GÜNDÜZ P., KIRMIZI B. A., BAKIRARAR B., SAK S., et al.
SNMMI 2021 Virtual Annual Meeting, 11 June 2021, (Full Text)
2018
201830. A prospective analysis on the frequency and predictive value of minimal residual disease assessment by flow cytometry and PET-CT imaging among myeloma patients on/off maintenance
BEKSAÇ M., CENGİZ SEVAL G., ŞAHİN U., MERTER M., İPEK Ş., ÖZKAN E., et al.
23rd Congress of the European Hematology Association, 2021, 14 June 2018, pp.249, (Full Text)
2021
202131. Radiomics analyses in 18F-FDG PET images of breast carcinoma to predict hormone reseptor status: histopathological correlational study.
ARAZ M., SOYDAL Ç., GÜNDÜZ P., KIRMIZI B. A., BAKIRARAR B., SAK S., et al.
SNMMI 2021 Virtual Annual Meeting, 11 June 2021, vol.62, pp.1100, (Summary Text)
2021
202133. Bilateral adrenal masses caused by extramedullary hematopoiesis detected by 18F-FLT PET/CT
KORKMAZ F. N., DEMİR Ö., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., CEYHAN K., et al.
23rd Eupopean Congress of Endocrinology 2021, 22 May 2021, vol.73, (Full Text)
2021
202134. Postinduction FDG-PET imaging improves the impact of biochemical response assessment on transplant outcome.
Cengiz Seval G., Özkan E., Araz M., Kırcalı E., Koyun D., Gürman G., et al.
8th International Congress on Leukemia Lymphoma Myeloma, 2021, İstanbul, Turkey, 21 May 2021, vol.38, pp.45, (Full Text)
2021
202135. Hipofiz hastalıklarında hibrid görüntüleme tekikleri
ÖZKAN E.
İstanbul Hipofiz Sempozyumu, 08 April 2021
2021
202136. Correlation between serum thyroglobulin levels and involved neck compartment in persistent/recurrent mode metastasis of papillary thyroid carcinoma
BAHÇECİOĞLU MUTLU A. B., ÖZKAN E., ARAZ M., ELHAN A. H., ERDOĞAN M. F.
19th İnternational Congress of Endocrinology, 2021, 24 February 2021, (Full Text)
2020
202037. Diferansiye tiroid kanseri takibinde F-18-FDG PET/MR’xxnin PET/BT’xxye katkısı
ARAZ M., ÖZKAN E., BALTACIOĞLU M. H., KIR K. M., KÜÇÜK N. Ö., PEKER E., et al.
32.Ulusal Nükleer Tıp Kongresi, Turkey, 20 - 21 November 2020, vol.6, pp.30-31, (Full Text)
2020
202038. Kolorektal kanser karaciğer metastazlarında transarteriyel radyoembolizasyon sonrası anjiogenik yatınıt prognostik önemi
SOYDAL Ç., NAK D., ARAZ M., Durmaz M., ÖZKAN E., ERGÜDER B. İ., et al.
32.Ulusal Nükleer Tıp Kongresi, Turkey, 20 - 21 November 2020, vol.6, pp.3, (Full Text)
2020
202039. FOLİKÜLER LENFOMADA BAZAL PET’ TE TOPLAM METABOLİK TÜMÖR HACMİ VE TOPLAM LEZYON GLİKOLİZİNİN PROGNOSTİK ÖNEMİ
Kırcalı E., Cengiz Seval G., Araz M., Uslu A., Öztürk C., Koyun D., et al.
46. Ulusal Hematoloji Kongresi, Antalya, Turkey, 28 - 31 October 2020, no.278, pp.105, (Full Text)
2020
202040. Foliküler lenfomada bazal PET'te toplam metabolik tümör hacmi ve toplan lezyon glikolizinin prognostik önemi.
CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., ÖZKAN E., et al.
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, (Full Text)
2019
201941. Detectability of 18F-Choline PET/MR in primary hyperparathyroidism with negative neck ultrasound and Tc-99m MIBI scintigraphy
ARAZ M., AKKUŞ P., SOYDAL Ç., ÖZKAN E., KIR K. M.
EANM 2019, 12 - 16 October 2019, vol.46, (Summary Text)
2019
201942. Prognosis estimation with the ratio of largest tumor diameter to total tumar diameter in multifocal T1 differentiated thyroid cancer
ARAZ M., AKKUŞ P., SOYDAL Ç., ÖZKAN E., KIR K. M.
Annual Congress of the EANM 2019, 12 - 16 October 2019, vol.46, pp.952, (Summary Text)
2019
201943. Prognosis estimation with the ratio of largest tumor diameter to total tumor diameter in multifocal T1 differentiated thyroid cancer
ARAZ M., Akkus P., SOYDAL Ç., ÖZKAN E., KIR K. M.
32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, Spain, 12 - 16 October 2019, vol.46, (Summary Text)
2019
201944. Clinical outcome of low risk differentiated thyroid cancer patients treated with 30 mCi for ablation or without radioactive iodine therapy: a single center experience fron Turkey
ÖZKAN E., AKKUŞ P., BAHÇECİOĞLU MUTLU A. B., ARAZ M., SOYDAL Ç., GÜLLÜ S., et al.
SNM 2019 Annual Meeting, 22 - 25 June 2019, vol.60, (Summary Text)
2019
201945. Comparison of bone sncitigraphy and Ga-68-PSMA PET/CT in the detection of bone metastases of prostate carcinoma
SOYDAL Ç., NAK D., ARAZ M., AKKUŞ P., ÜRÜN Y., ÖZKAN E., et al.
8th Balkan Congress Nuclear Medicine, 10 - 14 April 2019, (Summary Text)
2018
201847. Ac-225 PSMA ve Bi-213 PSMA ve Vadediyor?
ÖZKAN E.
Nükleer Tıp Sempozyumu, Turkey, 16 - 17 November 2018
2018
201848. Prognostic value of metabolikc parameters on baseline 18F FDG PET/CT in small cell lung cancer
ARAZ M., SOYDAL Ç., ÖZKAN E., ŞEN E., NAK D., KÜÇÜK N. Ö.
Annual Congress of the EANM 2018, 13 - 17 October 2018, (Summary Text)
2018
201849. AKCİĞER KANSERİNDE PRİMER TÜMÖRÜN SUVMAX DEĞERİ İLE HİSTOPATOLOJİK TANI ÖN GÖRÜLEBİLİR Mİ?
YENİGÜN B. M., KOCAMAN G., SOYDAL Ç., KARASOY D., KAHYA Y., ÖZKAN E., et al.
VIII. ULUSAL AKCİĞER KANSERİ KONGRESİ, Muğla, Turkey, 4 - 07 October 2018, (Summary Text)
2018
201850. Akciğer kanserinde primer tümörün SUVmax değeri ile histopatolojik tanı ön görülebilir mi?
YENİGÜN B. M., KOCAMAN G., SOYDAL Ç., KAHYA Y., ÖZKAN E., SAK S., et al.
VII.Ulusal AKciğer KAnseri Kongresi, Turkey, 4 - 07 October 2018, pp.167, (Summary Text)
2018
201851. Akciğer kanserinde primer tümörün SUVmax değeri ile histopatolojik tanı ön görülebilir mi?
Yenigün B. M., Kocaman G., Soydal Ç., Kahya Y., Özkan E., Sak S., et al.
VII.Ulusal Akciğer Kanseri Kongresi, Turkey, 4 - 07 October 2018, pp.167, (Summary Text)
2018
201852. Prognostic Value Of Metabolic Parameters On Baseline 18F FDG PET/CT In Small Cell Lung Cancer
ARAZ M., SOYDAL Ç., ÖZKAN E., Sen E., Nak D., KÜÇÜK N. Ö., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text)
2018
201853. Prognostic importance of serum PSA response in patients who received Luttetium-177 prostate specific antigen treatment for castration resistant prostate cancer
SOYDAL Ç., ARAZ M., ÜRÜN Y., Nak D., ÖZKAN E., KÜÇÜK N. Ö.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text)
2018
201854. The Efficacy of 18F Choline PET/CT in comparison to Tc99m MIBI SPECT/CT in the Localisation of Hyperfunctioning Parathyroid Gland in primary Hyperparathyroidism
ARAZ M., SOYDAL Ç., ÖZKAN E., KIR K. M., İBİŞ E., Gullu S., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text)
2018
201855. The Related Factors with Brown Fat Activation in 18F-FDG PET/CT
SOYDAL Ç., ARAZ M., Gulpinar B., Akkus P., ÖZKAN E., Sahin M.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text)
2018
201856. The role of Thyroglobulin doubling time in the follow up of differentiated thyroid cancer and its relationship with demographic and histopathologic risk factors and with 18F FDG PET/CT parameters
ARAZ M., SOYDAL Ç., ÖZKAN E., Akkus P., Nak D., KÜÇÜK N. Ö., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text)
2018
201857. Evaluation of chemocine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma
ÖZKAN E., SOYDAL Ç., Sahin U., KÜÇÜK N. Ö., Beksac M., Ozturk C., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text)
2018
201858. Relationship between baseline metabolic 18 FDG parameters and survival malignant pleural mesothelioma: A single centre experience
KAHYA Y., SOYDAL Ç., YENİGÜN B. M., ÖZKAN E., tutkun n. a., ENÖN S., et al.
ERS Internatıonal Congress, 15 - 19 September 2018, (Summary Text)
2018
201859. Evaluation of chemokine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma
ÖZKAN E., SOYDAL Ç., ŞAHİN U., KÜÇÜK N. Ö., BEKSAÇ M., Öztürk C., et al.
Annual Congress of the European Association of Nuclear Medicine, Düsseldorf, Germany, 13 - 17 October 2018, vol.45, pp.583, (Summary Text)
2018
201860. Relationship between baseline metabolic 18F-FDG parameters and survival in malignant pleural mesothelioma: A single centre experience
KAHYA Y., SOYDAL Ç., Yenigun M. B., ÖZKAN E., ATA TUTKUN N., ENÖN S., et al.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52, (Summary Text)
2018
201861. A prospective analysis on the frequency and predictive value of minimal residual disease asessment by flow cytometry and PET-CT imaging among myeloma patients on/off maintenance
BEKSAÇ M., CENGİZ SEVAL G., ŞAHİN U., MERTER M., İPEK Ş., ÖZKAN E., et al.
23rd Congress of European Hematology Association, 14 - 17 June 2018, (Summary Text)
2018
201862. Çoğu hastaya RAI gerekmeyebilir veya düşük doz yeterlidir.
ÖZKAN E.
40.Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Turkey, 9 - 13 May 2018
2018
201863. Metastatik PCa’xxda teranostik nükleler tıp uygulamaları
ÖZKAN E.
Türk Üroloji Akademisi Multidisipliner Ürolojik Onkoloji Kursu, Turkey, 28 April 2018
2018
201864. Erken evre hodgkin lenfomada progresyonsuz sağkalımı belirlemede FDG pET/BT parametrelerinin değeri
ÖZKAN E., SOYDAL Ç., NAK D., CİVRİZ BOZDAĞ S., ARAZ M., SENO C., et al.
30.Ulusal Nükleer Tıp Kongresi, Turkey, 11 - 15 April 2018, (Summary Text)
2018
201865. 18F-Florokolin ile radioguided paratiroidektomi
DEMİREL S. K., DEMİR A., ÖZKAN E., KÜÇÜK N. Ö., KORKMAZ M.
21.Ulusal Cerrahi Kongresi, Turkey, 11 - 15 April 2018, (Summary Text)
2018
201866. Lu-177 PSMA tedavisi uygulanan kastrasyona dirençli metastatik prostat kanserli hastalarda serum PSC yanıtının prognostik önemi
ÖZKAN E., SOYDAL Ç., NAK D., CİVRİZ BOZDAĞ S., ARAZ M., SENO C., et al.
30.Ulusal Nükleer Tıp Kongresi, Turkey, 11 - 15 April 2018, (Summary Text)
2018
201867. Primer hiperparatiroidi hastalarında hiperfonksiyone paratiroid bezinin lokalizasyonunda F-18 Kolin PET/BMT’nin rolü ve Tc-99m MIBI SPECT/BT ile karşılaştırılması
ARAZ M., SOYDAL Ç., ÖZKAN E., KIR K. M., İBİŞ E., GÜLLÜ S., et al.
30.Ulusal Nükleer Tıp Kongresi, Turkey, 11 - 15 April 2018, (Full Text)
2018
201868. Diferansiye tiroid kanseri hastalarının takibinde tiroglobulin doubling time’xxin yeri, bazal demografik ve histopatalojik risk faktörleri ve F-18 FDG PET/BT parametreleri ile ilişkisi
ÖZKAN E., SOYDAL Ç., NAK D., CİVRİZ BOZDAĞ S., ARAZ M., SENO C., et al.
30.Ulusal Nükleer Tıp Kongresi, Turkey, 11 - 15 April 2018, (Summary Text)
2017
201769. Baş, boyun kanserli hastaların takibinde 18F-FDG-Positron emisyon tomografisi/bilgisayarlı tomografinin geçerlilik ve güvenilirliği
KABAŞ UYSAL Z., ÖZKAN E., KÜÇÜK N. Ö., SOYDAL Ç., TEZCANER Z. Ç., GÖKCAN M. K., et al.
39.Türk Ulusal Kulak Burun Boğaz ve Baş Boyun Cerrahisi Kongresi, Turkey, 8 - 12 November 2017, (Full Text)
2017
201770. Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma
SOYDAL Ç., ÖZKAN E., NAK D., ELHAN A. H., KÜÇÜK N. Ö., KIR K. M.
Erupoean Association of Nuclear Medicine, 21 - 25 October 2017, vol.44, (Summary Text)
2017
201771. The value of volumetric 18F-FDG PET parameters in pediatric patients with bone sarcoma
ÖZKAN E., KHALILZADEH M., SOYDAL Ç., TAÇYILDIZ N., KÜÇÜK N. Ö., KIR K. M.
European Association of Nuclear Medicine, 21 - 25 October 2017, vol.44, (Summary Text)
2017
201772. Analyisi of long-term clinical follow-up outcome, demographic and histopatlological risk factors in a large DTC series
SOYDAL Ç., ÖZKAN E., NAK D., KÜÇÜK N. Ö., KIR K. M.
EANM 2017, 21 - 25 October 2017, vol.44, pp.399, (Summary Text)
2017
201773. Experience of 18F Flourodeoxy glucose (FDG) positron emission tomography (PET) - Computted tomography (CT) in testicular carcinoma
SOYDAL Ç., ÜRÜN Y., NAK D., ÖZKAN E., KÜÇÜK N. Ö.
SNMMI 2017 Annual Meeting, 22 - 26 June 2017, vol.58, pp.1069, (Summary Text)
2017
201774. Can serum prostat specific antigen levels be a predictor for 68Ga PSMA PET/CT positivity?
SOYDAL Ç., ÜRÜN Y., NAK D., ÖZKAN E., KÜÇÜK N. Ö.
SNMMI 2017 Annual Meeting, 22 - 26 June 2017, vol.58, pp.1078, (Summary Text)
2017
201775. Relationship between baseline metabolic 18F-FDG parameters and survival in malignant pleural mesothelioma
KAHYA Y., SOYDAL Ç., YENİGÜN B. M., ÖZKAN E., ATA TUTKUN N., ENÖN S., et al.
SNMMI 2017 Annual Meeting, 22 - 26 June 2017, vol.58, pp.149, (Summary Text)
2017
201776. Experience of 18F Flourodeoxy glucose (FDG) positron emission tomography (PET)-computed tomography (CT) in testicular carcinoma
SOYDAL Ç., ÜRÜN Y., NAK D., ÖZKAN E., KÜÇÜK N. Ö.
SNM Annual Meeting, Denver, Colorado, United States Of America, 10 - 14 June 2017, vol.58, pp.1069, (Summary Text)
2017
201777. Can serum prostat specific antigen levels be a predictor for 68Ga PSMA PET/CT positivety?
SOYDAL Ç., ÜRÜN Y., SÜER E., NAK D., ÖZKAN E., KÜÇÜK N. Ö.
SNMMI 2017 Annual Meeting, Denver, Colorado, United States Of America, 10 - 14 June 2017, vol.58, pp.1078, (Summary Text)
2017
201778. N-13 Amonyak krdiyak PET görüntüleme: İlk deneyimler
KÜÇÜK N. Ö., SOYDAL Ç., ÖZKAN E., KIR K. M.
29.Ulusal Nükleer Tıp Kongresi, Turkey, 10 - 14 May 2017, vol.3, pp.66, (Summary Text)
2017
201779. PRRT: Hasta seçimi, uygulama ve izlem
ÖZKAN E.
29.Ulusal Nükleer Tıp Kongresi, Turkey, 10 - 14 May 2017, (Summary Text)
2017
201780. N-13 amonyak kardiyak PET görüntüleme: ilk deneyimler
KÜÇÜK N. Ö., SOYDAL Ç., ÖZKAN E., KIR K. M.
29.Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 10 - 14 May 2017, (Summary Text)
2017
201781. Hayvan PET/BT görüntüleme deneyimimiz
SOYDAL Ç., KÜÇÜK N. Ö., ÖZKAN E., KIR K. M.
29.Ulusal Nükleer Tıp Kongresi, Turkey, 10 - 14 May 2017, vol.3, pp.38, (Summary Text)
2017
201782. Additive value of dynamic risk stratification in the management of differentiated thyroid carcinoma patients
ÖZKAN E., SOYDAL Ç., Nak D., Kucuk N., Kucuk N., KIR K. M.
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Colorado, United States Of America, 10 - 14 June 2017, vol.58, (Summary Text)
2017
201783. Experience of F-18 Flourodeoxy glucose (FDG) positron emission tomography (PET) -computed tomography (CT) in testicular carcinoma
SOYDAL Ç., ÜRÜN Y., Nak D., ÖZKAN E., KÜÇÜK N. Ö.
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Colorado, United States Of America, 10 - 14 June 2017, vol.58, (Summary Text)
2017
201784. Relationship between baseline metabolic F-18-FDG parameters and survival in malignant pleural mesothelioma
KAHYA Y., SOYDAL Ç., Yenigun M. B., ÖZKAN E., Tutkun N. A., ENÖN S., et al.
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Colorado, United States Of America, 10 - 14 June 2017, vol.58, (Summary Text)
2017
201785. Küratif Cerrahi Uygulanan Akciğer Kanserli Hastalarda Preoperatif Beslenme Skoru İle Primer Tümörün 18F-FDG PET/BT’de Ölçülen SUV Max Tutulumu Arasındaki İlişki: Tek Merkez Deneyimi
KAHYA Y., HAMZAYEV E., GÜNEŞ S. G., SOYDAL Ç., YENİGÜN B. M., ÖZKAN E., et al.
ULUSAL AKCİĞER SAĞLIĞI KONGRESİ 2017, Antalya, Turkey, 15 - 19 March 2017, (Summary Text)
2016
201686. MALİGN PLEVRAL MEZOTELYOMADA 18F FDG PET BT PARAMETRELERİNİN SAĞKALIM İLE İLİŞKİSİ TEK MERKEZ DENEYİMİ
KAHYA Y., YENİGÜN B. M., ÖZKAN E., ATA TUTKUN N., ÖZKAN M., SOYDAL Ç., et al.
VII. ULUSAL AKCİĞER KANSERİ KONGRESİ, Turkey, 24 - 27 November 2016
2016
201687. Malign plevral mezotelyomada 18F-FDG PET/BT parametrelerinin sağkalım ile ilişkisi: tek merkez deneyimi
Kahya Y., Özkan E., Yenigün B. M., Ata Tutkun N., Özkan M., Soydal Ç., et al.
VII.Ulusal Akciğer Kanseri Kongresi, Antalya, Turkey, 24 - 27 November 2016, pp.100, (Summary Text)
2016
201688. The first experience on Lutetium lu 177 prostate specific antigen PSMA treatment in castration resistant prostate cancer patients
SOYDAL Ç., ÖZKAN E., NAK D., KÜÇÜK N. Ö.
Annual Congress of the European Association of Nuclear Medicine, 15 - 19 October 2016
2016
201689. Yaygın Kemik Ağrıları ile Göğüs Hastalıklarına Başvuran Kadın Hasta
ACAR D., GÜLBAY B., KARNAK D., BAŞARIR K., ATASOY K. Ç., ÖZKAN E.
Türkiye Solunum Araştırmaları Derneği'nin 38. Ulusal Kongresi SOLUNUM 2016 İzmir, Turkey, 15 - 19 October 2016, (Summary Text)
2016
201690. The first experience on Lutetium (lu)-177 prostate specigic andigen (PSMA) treatment in castration resistant prostate cancer patients
SOYDAL Ç., ÖZKAN E., NAK D., KÜÇÜK N. Ö.
Annual Congress of the European Association of Nuclear Medicine, 15 - 19 October 2016, vol.43, pp.415, (Summary Text)
2015
201591. Stress Myocardial Perfusion Imaging Compared to Coronary Computed Tomography in Patients With Suspected Coronary Artery Disease: an International Randomized Controlled Trial
Karthikeyan G., Salobir B. G., Jug B., Alexanderson E., Devasenapathy N., Vitola J., et al.
Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association (AHA), Florida, United States Of America, 7 - 11 November 2015, vol.132, (Summary Text)
2015
201592. Effect of applmication of prophylactic central compartment lymp node dissection to radioiodine ablation doses in patients with papillary thyroid carcinoma
SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.
Annual Congress of the European Association of Nuclear Medicine, 10 - 14 October 2015, vol.42, pp.726, (Summary Text)
2015
201593. Effect of application of prophylactic central compartment lymph node dissection to radioiodine ablation doses in patients with papillary thyroid carcinoma
SOYDAL Ç., ÖZKAN E., Kucuk N. O., KIR K. M.
28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Germany, 10 - 14 October 2015, vol.42, (Summary Text)
2015
201594. Kalsitonin negatif boyanma gösteren medüller tiroid karsinomu vakası
GÖKÇAY CANPOLAT A., DEMİR Ö., ÖZKAN E., ŞAHİN M., EMRAL R., UYSAL A. R., et al.
37. TEMD Kongresi, Turkey, 6 - 10 May 2015
2015
201595. Evaluation of extrapulmonary Ga 67 uptake in sarcoidosis A retrospective analysis
Küçük N. Ö., Özkan E., Gülev B., Aras G., Kır K. M.
Annual Congress of EANM, Hamburg, Germany, 25 - 29 April 2015, vol.28, pp.436, (Summary Text)
2015
201596. Upgrade Of FDG-PET Response Following Autologous Stem Cell Transplantation Is Associated With Better Progression Free Survival Among Patients With Multiple Myeloma
Beksac M., Topcuoglu P., Gunduz M., Ataca P., Ozturk S. M. B., Kirazli B., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, (Summary Text)
2014
201497. Impact of PET-CT Response on Survival Parameters Following Autologous Stem Cell Transplantation Among Patients with Multiple Myeloma: Comparison of Two Cut-Off Values
BEKSAÇ M., Gunduz M., Ozen M., Ozturk S. M. B., KÜÇÜK N. Ö., ÖZKAN E.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text)
2014
201498. Diferansiye tiroid kanserlerinde bazal tiroglobulin düzeyleri rekürren ve persistan hastalığı predikte ettirebilir.
AYDOĞAN B. İ., ERDOĞAN M. F., ÖZTÜRK B., ÖZKAN E., ŞAHİN M., EMRAL R., et al.
6. Türkiye Tiroid Hastalıkları Kongresi, Ankara, Turkey, 28 - 29 November 2014, (Summary Text)
2014
201499. The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of respon8se to fixed dose peptide receptor radionuclide therapy with Lu-177 DOTATATE
SOYDAL Ç., PEKER A., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.
Annual Congress of the European Association of Nuclear Medicine, 18 - 22 October 2014, vol.41, pp.225, (Summary Text)
2014
2014100. Effect of Presence of Extrahepatic Metastases to Survival After Selective Radiation Therapy for Liver Metastases of Breast Cancer
SOYDAL Ç., Kucuk O. N., ÖZKAN E., Bali E., Bilgic S., KIR K. M.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, Sweden, 18 - 22 October 2014, vol.41, (Summary Text)
2014
2014101. Value of Ga-68 DOTATATE PET/CT in Patients with Suspected Neuroendocrine Tumors
SOYDAL Ç., ÖZKAN E., Bali E., Kucuk O. N., KIR K. M.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, Sweden, 18 - 22 October 2014, vol.41, (Summary Text)
2014
2014102. Outcome of Peptide Receptor Radionuclide Treatment with Lu-177 DOTATATE from Ankara University.
SOYDAL Ç., Peker A., ÖZKAN E., Kucuk O. N., KIR K. M.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, Sweden, 18 - 22 October 2014, vol.41, (Summary Text)
2014
2014103. Küçük hücreli dışı akciğer kanserinin N evrelemesinde klinik ve radyolojik değerlendirme yöntemlerinin etkinliği Sözlü Sunum 09
BULUT E., GONCA Ç., SAKALLI M. A., DUMAN E., ŞAHİN M., KOCAMAN G., et al.
VI. Ulusal Akciğer Kongresi, Antalya, Turkey, 8 - 11 May 2014, pp.82
2014
2014104. Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy
SOYDAL Ç., Keskin O., KÜÇÜK N. Ö., Bilgic S., ÖZKAN E., İDİLMAN R., et al.
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Missouri, United States Of America, 7 - 11 June 2014, vol.55, (Summary Text)
2014
2014105. Hepatoselüler kanserli hastalarda selektif internal radyasyon tedavisi sonrası sağkalımı öngörmede prognostik faktörler
SOYDAL Ç., KESKİN O., KÜÇÜK N. Ö., İDİLMAN R., ÖZKAN E., BİLGİÇ M. S., et al.
26.Ulusal Nükleer Tıp Kongresi, Turkey, 16 - 20 April 2014, pp.17, (Summary Text)
2014
2014106. Meme kanseri karaciğer metastazı nedeniyle selektif internal radyasyon tedavisi uygulanan hastalarda ekstrahepatik metastaz varlığının sağkalım üzerine etkisi
SOYDAL Ç., KÜÇÜK N. Ö., ÖZKAN E., BİLGİÇ M. S., BALİ E., KIR K. M.
26.Ulusal Nükleer Tıp Kongresi, Turkey, 16 - 20 April 2014, pp.53, (Summary Text)
2014
2014107. Lu-177 DOTATATE tedavsine yanıtın metabolik ve radyolojik olarak değerlendirilmesi
SOYDAL Ç., PEKER A., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.
26.Ulusal Nükleer Tıp Kongresi, Turkey, 16 - 20 April 2014, pp.15, (Summary Text)
2014
2014108. Lu-177 DOTATATE tedavisine yanıt Ga-68 DOTATATE PET/BT ile tahmin edilebilir mi?
SOYDAL Ç., PEKER A., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.
26.Ulusal Nükleer Tıp Kongresi, Turkey, 16 - 20 April 2014, pp.53, (Summary Text)
2013
2013109. Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
SOYDAL Ç., Yuksel C., Kucuk O. N., Okten I., ÖZKAN E., Erdogan B. D.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, France, 19 - 23 October 2013, vol.40, (Summary Text)
2013
2013110. Basal thyroglobulin levels may predict recurrent and persistend disease in differentiated thyroid cancer DTC
AYDOĞAN B. İ., ERDOĞAN M. F., ÖZTÜRK B., ÖZKAN E., ŞAHİN M., EMRAL R., et al.
37th Annual Meeting of the ETA, 7 - 11 September 2013, vol.2, pp.142
2013
2013111. High thyroglobulin levels at remnant ablation may predict recurnet persistent disaese in defferentiated thyroid cancer DTC
Aydoğan B. İ., Erdoğan M. F., Güllü S., Can F., Yüksel B., Özkan E., et al.
37th Annual Meeting of the ETA, Leiden, Netherlands, 7 - 11 September 2013, vol.2, pp.161, (Summary Text)
2013
2013112. BASAL THYROGLOBULIN LEVELS MAY PREDICT RECURRENT AND PERSISTENT DISEASE IN DIFFERENTIATED THYROID CANCER (DTC)
AYDOĞAN B. İ., ERDOĞAN M. F., ÖZTÜRK B., ÖZKAN E., ŞAHİN M., EMRAL R., et al.
37th Annual Meetingof the EuropeanThyroid Association, Leiden, Netherlands, 7 - 11 November 2013, vol.2, pp.75-194, (Summary Text)
2013
2013113. Metastatik kemik sarkomalı çocuklarda meoadjuvan tedavi ve ona eklenen sorafenib antivegf komniasyonuna yanıtı değerlendirmede Fluorine 18 Fluorodeoksiglukoz positron emission tomograpi 18F PET yönteminin önemi prognoz belirleyici olabilir mi
Taçyıldız N., Küçük N. Ö., Tanyıldız G., Özkan E., Yavuz L. G., Ünal E., et al.
20.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2013, pp.37, (Summary Text)
2012
2012114. REKOMBİNAN TSH ENJEKSİYONU VE LEVOTİROKSİN KESİLMESİ İLE YAPILAN TÜN VÜCUT TARAMA GÖRÜNTÜLERİNİN UYARILMIŞ TİROGLOBULİN DÜZEYLERİNİN HASTALIK REKÜRRENSİ AÇISINDAN RİSK GRUPLARINA GÖRE DEĞERLENDİRİLMESİ
ŞAHİN M., AYDOĞAN B. İ., YÜKSEL B., ERDOĞAN M. F., GÜLLÜ S., EMRAL R., et al.
5.TÜRKİYE TİROİD HASTALIKLARI KONGRESİ, Turkey, 23 - 24 November 2012, (Summary Text)
2012
2012115. Serviks kanserinin pelvik ve paraaortik lenf nodu evrelemesinde 18F-FDG PET/BT'nin rolü
SOYDAL Ç., İBİŞ E., ORTAÇ U. F., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M., et al.
13.Ulusal Jinekolojik Onkoloji Konresi, Turkey, 7 - 11 November 2012, pp.82, (Summary Text)
2012
2012116. The diagnostic role of 68Ga DOTATATE PET CT in the detection of gastroienteropancreatic neuroendocrine tumors comparison with 111In octreotide scintigraphy and CT scan
Sobhanı S., Küçük N. Ö., Özkan E., İbiş E., Kır K. M.
Annual Congress of EANM, Milan, Italy, 27 - 31 October 2012, vol.39, pp.1035, (Summary Text)
2012
2012117. Predictive value of pre-transplant FDG-PET/CT in newly diagnosed multiple myeloma (MM) patients
ÖZKAN E., KÜÇÜK N. Ö., BEKSAÇ M., Dingli D., Lowe V. J., Nanni C., et al.
25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, Italy, 27 - 31 October 2012, vol.39, (Summary Text)
2012
2012118. The role of 18F-FDG PET/CT in pelvic and paraaortic lymph node staging of uterine cervical cancer
SOYDAL Ç., İBİŞ E., Ortac F., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.
25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, Italy, 27 - 31 October 2012, vol.39, (Summary Text)
2012
2012119. 18F-FDG PET/CT in Initial Staging of Gastric Cancer
Filik M., KIR K. M., Aksel B., ÖZKAN E., KÜÇÜK N. Ö., İBİŞ E., et al.
25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, Italy, 27 - 31 October 2012, vol.39, (Summary Text)
2012
2012120. 68Ga DOTATATE accumulation in sarcoidosis
KÜÇÜK N. Ö., SOYDAL Ç., ÖZKAN E., ÖZDEMİR KUMBASAR Ö., İBİŞ E.
25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, Italy, 27 - 31 October 2012, vol.39, (Summary Text)
2013
2013121. Comparison of preablative thyroglubolin level with the other risk factors in determining papillary thyroid cancer prognosis
ÖZKAN E., GENÇ Y., ARAZ M., SOYDAL Ç., ARAS G., KIR K. M.
SNM Annual Meeting, 8 - 12 June 2013, vol.54, (Summary Text)
2012
2012122. Evlauation of the response to SIRT in patients with HCC according to pretreatment MAA uptake
KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., ÖZKAN E., ARAS G.
SNM Annual Meeting, 9 - 13 June 2012, vol.53, pp.227, (Summary Text)
2012
2012123. CT and 18F-FDG PET/CT in staging or restaging of renal cell corcinoma
ÖZKAN E., ARAZ M., SOYDAL Ç., FİLİK M., ARAS G.
SNM Annual Meeting, 9 - 13 June 2012, vol.53, pp.300, (Summary Text)
2012
2012124. Prognostic value of post-induction PET/CT in untreated multiple myeloma (MM) patients undergoing autologous stem cell transplant (ASCT)
Kostakoglu L., Dingli D., Beksac M., Zamagni E., Mark T. M., Chari A., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30, (Summary Text)
2012
2012125. The role of 68Ga DOTATATE pET CT in detection of distant metastasis in patient with hepatocellular cancer
Küçük N. Ö., Sobhanı S., Özkan E., İbiş E.
1st Balkan Congress of Nucl Med, Antalya, Turkey, 4 - 08 April 2012, pp.79, (Summary Text)
2012
2012126. The diagnostic role of 68Ga Peptide PET CT in the detection of gastroenteropancreatic neuroendocrine tumors comparison with 111In Octreotide scintigraphy and CT scan
Küçük N. Ö., Sobhanı S., Özkan E., İbiş E.
1st Balkan Congress of Nucl Med, Antalya, Turkey, 4 - 08 April 2012, pp.65, (Summary Text)
2012
2012127. Evaluation of the response to SIRT in patients with HCC according to pretreatment MAA uptake
KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., ÖZKAN E., ARAS G.
1st Balkan Congress of Nuclear Medicine, 4 - 08 April 2012, pp.27, (Summary Text)
2011
2011128. The role of 18F FDG PET CT in the preoperative staging and post therapy follow up Comparison with spiral CT
Özkan E., Araz M., Soydal Ç., Küçük N. Ö.
International Congress on Clinical PET and Molecular Nuclear Medicine, Vienna, Austria, 8 - 11 November 2011, pp.86, (Summary Text)
2011
2011129. Intra arterial radioembolization with Y 90 for unresectable primary and metastatic liver tumours
Küçük N. Ö., Soydal Ç., Laçin S., Özkan E., Bilgiç S.
International Congress on Clinical PET and Molecular Nuclear Medicine, Vienna, Austria, 8 - 11 November 2011, pp.199, (Summary Text)
2011
2011130. The role of PET/CT in the evaluation of panceratic cancer and suspected pancreas masses
ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
International Congerence on Clinical PET and Molecular Nuclear Medicine, 8 - 11 November 2011, pp.87, (Summary Text)
2011
2011131. Intra-arterial radioembolization with Y-90 for unresectable primary and metastatic liver tumaours
ÖZKAN E., SOYDAL Ç., LAÇİN S., BİLGİÇ M. S.
International Congerence on Clinical PET and Molecular Nuclear Medicine, 8 - 11 November 2011, pp.194, (Summary Text)
2011
2011132. Intra arterial radioembolization with Y 90 for unresectable primary and metastatic liver tumors and evaluation of treatment response by FDG PET CT
KÜÇÜK N. Ö., SOYDAL Ç., LAÇİN S., ÖZKAN E., ARAZ M., İBİŞ E.
Annual Congress of EANM, 15 - 19 October 2011, vol.38, pp.371-372
2011
2011133. The role of 18F FDG PET CT in detecting colorectal cancer recurrence in patients with elevated CEA level
ÖZKAN E., SOYDAL Ç., ARAZ M., İBİŞ E., KIR K. M., KÜÇÜK N. Ö.
Annual Congress of EANM, 15 - 19 October 2011, vol.38, pp.241
2011
2011134. The role of 18F-FDg positron emission tomography/computed tomography in detecting carcinoma of unknown primary
ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö., ARAS G.
Annual Congress of the European Association of Nuclear Medicine, 15 - 19 October 2011, vol.38, pp.384, (Summary Text)
2011
2011135. A retrospective analysis of 18F-FDG PET/CT in the primary staging of non-small cell cancer (NSCLS)
ÖZKAN E., ARAZ M., SOYDAL Ç., ARAS G.
Annual Congress of the European Association of Nuclear Medicine, 15 - 19 October 2011, vol.38, pp.125, (Summary Text)
2011
2011136. Impcat of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
ÖZKAN E., SOYDAL Ç., KÜÇÜK N. Ö., İBİŞ E., ERBAY G.
Annual Congress of the European Association of Nuclear Medicine, 15 October - 19 November 2011, vol.38, pp.347, (Summary Text)
2011
2011137. Impact of 18F FDG positron emission tomography computed tomography for detecting unknown primary tumor
Özkan E., Soydal Ç., Araz M., Küçük N. Ö., Aras G.
SNM Annual Meeting, Texas, United States Of America, 4 - 08 June 2011, vol.52, pp.1923, (Summary Text)
2011
2011138. The impact of 18F FDG PET CT in staging and restagign of multipl myeloma patients Comparison with conventional imaging tools
Özkan E., Yağcı Ş. G., Filik M., Küçük N. Ö.
SNM Annual Meetign, Texas, United States Of America, 4 - 08 June 2011, vol.52, pp.375, (Summary Text)
2011
2011139. Primer ya da metastatik karaciğer tümörlerinde intra arteriyal Y 90 mikroembolizasyon tedavisi
KÜÇÜK N. Ö., SOYDAL Ç., LAÇİN S., ÖZKAN E., BİLGİÇ M. S., İBİŞ E.
8.Ulusal Hepatoloji Kongresi, Turkey, 1 - 05 June 2011, pp.7
2011
2011140. CEA yüksekliği olan kolon kanserli hastalarda hastalık rekürrensinin saptanmasında 18F-FDG PET/BT'nin rolü
ÖZKAN E., SOYDAL Ç., KIR K. M., İBİŞ E., ERBAY G.
Ulusal Nükleer Tıp Kongresi, Turkey, 27 April - 01 May 2011, pp.157, (Summary Text)
2011
2011141. Myokard perfüzyon sintigrafisi sonuçlarının retrospektif analizi ve koroner anjiografi ili korelasyonu.
ARAZ M., SOYDAL Ç., SOBHANI S., ÖZKAN E., KÜÇÜK N. Ö., İBİŞ E., et al.
23.Ulusal Nükleer Tıp Kongresi, 27 April 2011, pp.100, (Summary Text)
2011
2011142. Myokard perfüzyon sintigrafisinde adenozin sonuçlarımız.
ÖZKAN E., SOBHANI S., ARAZ M., KÜÇÜK N. Ö., KIR K. M., ERBAY G.
23.Ulusal Nükleer Tıp Kongresi, 27 April 2011, pp.101, (Summary Text)
2011
2011143. Hiperparatiroidide paratiroid sintigrafisi: Retrospektif analiz
ÖZKAN E., BALİ E., ARAZ M., SOYDAL Ç., KIR K. M., ERBAY G.
Ulusal Nükleer Tıp Kongresi, Turkey, 27 April - 01 May 2011, pp.69, (Summary Text)
2011
2011144. Primeri bilinmeyen kanserde 18F-FDG PET/BT'nin rolü
ÖZKAN E., SOYDAL Ç., ARAS G.
Ulusal Nükleer Tıp Kongresi, Turkey, 27 April - 01 May 2011, pp.175-176, (Summary Text)
2010
2010145. Is radioiodine treatment effective for childhood differentiated thyroid carcinomas Results of five years follow up
ÖZKAN E., SOYDAL Ç., ARAZ M., FİLİK M., YAĞCI Ş. G., KÜÇÜK N. Ö.
Annual Congres of EANM, 9 - 13 October 2010, vol.37, pp.488, (Summary Text)
2010
2010146. The role of PET/CT in the evaluation of pancreatic cancer and suspected pancreas masses
ÖZKAN E., SOYDAL Ç., ARAZ M., Filik M., Yagci S. G., KÜÇÜK N. Ö.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 9 - 13 October 2010, vol.37, (Summary Text)
2010
2010147. Incidental thyroid lesions identified by F18 FDG-PET/CT imaging
ÖZKAN E., KÜÇÜK N. Ö., Aras G.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 9 - 13 October 2010, vol.37, (Summary Text)
2010
2010148. Is FDG PET/CT useful in staging and restaging in multiple myeloma patients: comparison with radiologic imagings and clinical follow-up?
ÖZKAN E., Yagci S., Filik M., KÜÇÜK N. Ö.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 9 - 13 October 2010, vol.37, (Summary Text)
2010
2010149. A comparison of 18F-FDG PET/CT with 111-IN octreotide scan in neuroendocrine tumors
ÖZKAN E., Yagci S., Lacin S., KÜÇÜK N. Ö., Aras G.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 9 - 13 October 2010, vol.37, (Summary Text)
2010
2010150. Additional value of dual time point 18F-FDG PET/CT imaging in suspected pulmonary nodules
ÖZKAN E., Tari P., Yagci S., Lacin S., Erbay G.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 9 - 13 October 2010, vol.37, (Summary Text)
2010
2010151. The role of 18F-FDG-PET CT in malign melanome and comparison with conventional imaging modalities
ÖZKAN E., ARAZ M., SOYDAL Ç., Filik M., KÜÇÜK N. Ö.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 9 - 13 October 2010, vol.37, (Summary Text)
2010
2010152. The retrospective analysis of SUV of lesions detected on 18F-FDG PET/CT in differentiated thyroid cancer
ÖZKAN E., KÜÇÜK N. Ö., Lacin S., Aras G.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 9 - 13 October 2010, vol.37, (Summary Text)
2010
2010153. Küçük hücreli dışı akciğer kanserinde preoperatif lenf nodu evrelemesinde 18F FDG PET BT ve dual time görüntülemenin yeri
ÖZKAN E., KÜÇÜK N. Ö., LAÇİN S., ARAS G.
5.Ulusal Torasik Onkoloji Kongresi, Turkey, 17 - 19 June 2010, pp.3
2010
2010154. Differentiated thyroid carcinoma in childhood Clinical experience up to five years follow up period after radioiodine treatment
ÖZKAN E., SOYDAL Ç., ARAZ M., LAÇİN S., YAĞCI Ş. G., KÜÇÜK N. Ö.
SNM Annual Meetign, 5 - 09 June 2010, vol.51, pp.329
2010
2010155. F 18 FDG PET BT de insidental tiroid uptake inin retrospektif değerlendirilmesi 145 olgu
ÖZKAN E., KÜÇÜK N. Ö., ARAS G.
Türkiye Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2010, vol.19, pp.37
2010
2010156. The role of 18F FDG PET CT in malign melanoma and comparison with conventional imaging modalities
FİLİK M., ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö.
9th International Nuclear Oncology Congress, 25 - 29 April 2010, vol.19, pp.95
2010
2010157. Non Small Cell akciğer kanserinde preoperatif lenf nodu evrelemesinde 18F FDG PET BT ve dual time görüntülemenin yeri
ÖZKAN E., KÜÇÜK N. Ö., LAÇİN S., ARAS G.
Türkiye Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2010, vol.19, pp.35
2010
2010158. Medüller tiroid kanseri rekürrensini saptamada FDG PET BT nin yeri
ÖZKAN E., SOYDAL Ç., KÜÇÜK N. Ö., İBİŞ E., ERBAY G.
22.Ulusal Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2010, pp.158
2010
2010159. Diferansiye tiroid kanserinde F18 FDG PET BT de saptanan lezyonların SUV larının retrospektif analizi
ÖZKAN E., KÜÇÜK N. Ö., LAÇİN S., ARAS G.
Türkiye Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2010, vol.19, pp.36
2010
2010160. Medüller tiroid kanseri vakasında 18F FDG PET CT ve 111In Octreotide görüntüleme Olgu sunumu
LAÇİN S., ÖZKAN E., YAĞCI Ş. G., KÜÇÜK N. Ö.
Türkiye Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2010, vol.19, pp.160
2010
2010161. Myokard perfüzyon sintigrafisi sonuçlarının retrospektif analizi ve koroner anjiografi ile korelasyonu
ARAZ M., SOYDAL Ç., SOBHANI S., ÖZKAN E., KÜÇÜK N. Ö., İBİŞ E., et al.
22.Ulusal Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2010, pp.86
2010
2010162. Clinical experience of PET CT in soft tissue and osseos sarcomas
ÖZKAN E., SOYDAL Ç., FİLİK M., ARAZ M., KÜÇÜK N. Ö.
9th International Nuclear Oncology Congres, 25 - 29 April 2010, vol.19, pp.93
2010
2010163. The role of PET/CT in the evaluation of panceratic cancer ant suspected pancreatic masses
ÖZKAN E., SOYDAL Ç., ARAZ M., FİLİK M., YAĞCI Ş., KÜÇÜK N. Ö.
9th International Nuclear Oncology Congress, 25 - 29 April 2010, vol.19, pp.93-94, (Summary Text)
2009
2009164. Akciğer kanseri olgusunda renal staz ile karışan bilateral surrenal metastaz
ÖZKAN E., LAÇİN S., YAĞCI Ş., FİLİK M., ARAZ M., SOYDAL Ç., et al.
PET-BT Sempozyumu, Turkey, 12 - 15 November 2009, vol.18, pp.84, (Summary Text)
2009
2009165. İmmatür teratom takibine vetedaviye yanıtın değerlendirilmesinde 18F-FDG PET/CT: olgu sunumu
ÖZKAN E., LAÇİN S., YAĞCI Ş., FİLİK M., ARAZ M., SOYDAL Ç., et al.
PET/BT Sempozyumu, Turkey, 12 - 15 November 2009, vol.18, pp.85, (Summary Text)
2009
2009166. Y 90 Microsphere Therapy in Patients with Hemanjioendothelioma
KÜÇÜK N. Ö., LAÇİN S., ÖZKAN E.
56th SNM Annual Meeting, 13 - 17 June 2009, vol.50, pp.1106
2009
2009167. The Value of Dual Time FDG PET CT to Stage Lymph Nodes Preoperatively in Non Small Cell Lung Cancer
ÖZKAN E., LAÇİN S., YAĞCI Ş. G., KÜÇÜK N. Ö.
56th SNM Annual Meeting, 13 - 17 June 2009, vol.50, pp.1799
2009
2009168. Karaciğerde Hemangioendotelyoma Olgusunda Intraarteriyal 90Y Mikroküri Tedavisi
LAÇİN S., KÜÇÜK N. Ö., YAĞCI Ş. G., ÖZKAN E.
21.Ulusal Nükleer Tıp Kongresi, Turkey, 2 - 05 May 2009, vol.18, pp.114
2009
2009169. Gastrointestinal Stromal Tümörlerin Tedavi Sonrası Değerlendirilmesinde 18F PET BT nin Yeri
ÖZKAN E., LAÇİN S., KÖROĞLU R., YAĞCI Ş. G., KÜÇÜK N. Ö.
21.Ulusal Nükleer Tıp Kongresi, Turkey, 2 - 05 May 2009, vol.18, pp.44
2009
2009170. Lenfoma Hastalarının Evrelemesinde ve Tedavi Takibinde PET BT nin Rolü
ÖZKAN E., LAÇİN S., YAĞCI Ş. G., KÜÇÜK N. Ö.
21.Ulusal Nükleer Tıp Kongresi, Turkey, 2 - 05 May 2009, vol.18, pp.3
2009
2009171. İmmatür teratom takibinde ve tedaviye yanıtın değerlendirilmesinde 18F FDG PET CT Olgu sunumu
ÖZKAN E., LAÇİN S., YAĞCI Ş. G., FİLİK M., ARAZ M., SOYDAL Ç., et al.
Türkiye Nükleer Tıp Kongresi, Turkey, 2 - 05 May 2009, vol.18, pp.47
2009
2009172. Kadın Genital Tümörlerinde 18F FDG PET BT
ÖZKAN E., KÖROĞLU R., YAĞCI Ş. G., LAÇİN S., KÜÇÜK N. Ö.
21.Ulusal Nükleer Tıp Kongresi, Turkey, 2 - 05 May 2009, vol.18, pp.4
2008
2008173. When and why performed FDG PET in hodgkin disease
KÜÇÜK N. Ö., TARI P., ARAS G., ÖZKAN E.
Annuals Congress of EANM, 11 - 15 October 2008, vol.35, pp.285
2008
2008174. FDG PET CT in Female Genital Tumors Comparison with Correlative Imaging
KÜÇÜK N. Ö., KÖROĞLU R., ÖZKAN E.
55th SNM annual Meeting, 14 - 18 June 2008, vol.49, pp.443
2008
2008175. Tiroid karsinomalı bir olguda tüberkolaza sekonder yanlış pozitif F 18 FDG tutulumu
TOKMAK E., ÖZKAN E., KÜÇÜK N. Ö.
Türkiye Nükleer Tıp Kongresi, Turkey, 27 - 30 April 2008, vol.17, pp.4, (Summary Text)
2008
2008176. The value of three phase bone scintigraphy and Tc 99m labelled white blood cell imaging to evaluate acute infection
ÖZKAN E., KÜÇÜK N. Ö., TARI P., TOKMAK E., ARAS G.
Türkiya Nükleer Tıp Kongresi, Turkey, 27 - 30 April 2008, vol.17, pp.36
2008
2008177. The Value of PET CT for Staging in Head and Neck Carcinoma
TARI P., ÖZKAN E., KÖROĞLU R., KÜÇÜK N. Ö., ARAS G.
20.Ulusal Nükleer Tıp Kongresi, Turkey, 27 - 30 April 2008, vol.17, pp.6, (Summary Text)
2007
2007178. The Retrospective Evaluation of Metastatic Bone Disease in Differentiated Thyroid Carcinoma
KÜÇÜK N. Ö., ÖZKAN E., TOKMAK E., TARI P., ARAS G.
Annual Congress of the EANM, 13 - 17 October 2007, vol.34, pp.457
2007
2007179. PET/CT imaging in multiple myeloma-preliminary results
Kuecuek O., Kizil M., Oezkan E., Soydan E., Aras G., BEKSAÇ M.
20th Annual Congress of the European-Association-of-Nuclear-Medicine, Copenhagen, Denmark, 01 January 2007, vol.34, (Summary Text)
2007
2007180. The effectiveness of preoperative Tc-99m MIBI planar and pinhole SPECT parathyroid scanning in patients with primary and secondary hyperparathyroidism, correlation with gamma probe findings
Gultekin S., KIR K. M., Aras G., Erbay G., ÖZKAN E., Demirer S., et al.
20th Annual Congress of the European-Association-of-Nuclear-Medicine, Copenhagen, Denmark, 01 January 2007, vol.34, (Summary Text)
2007
2007181. PET CT Imaging in Multiple Myeloma Ankara University Experience Priliminary Results
KÜÇÜK N. Ö., KIZILÇAKAR M., ÖZKAN E., SOYDAN E., BEKSAÇ M., ARAS G.
54th SNM Annual Meeting, 2 - 06 June 2007, vol.48, pp.1514
2007
2007182. The value of acei scintigraphy in patients with suspicious renovascular hypertansiyon
ÖZKAN E., KÜÇÜK N. Ö., TARI P., KIR K. M.
XIII.International Symposium of Radionuclides in Nephrourology, 9 - 13 May 2007, pp.3, (Summary Text)
2007
2007183. F 18 FDG PET BT de yaygın tutulum izlenen sarkoidoz olguları
ÖZKAN E., KÜÇÜK N. Ö., ARAS G.
19.Ulusal Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2007, vol.16, pp.40
2007
2007184. Differansiye tiroid kanserinde metastatik kemik hastalığının retrospektif olarak değerlendirilmesi
KÜÇÜK N. Ö., ÖZKAN E., TOKMAK E., TARI P., ARAS G.
Türkiye Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2007, vol.16, pp.15
2007
2007185. Malign Plevral Mezotelyomalı Hastanın 18F FDG PET BT ile Preoperatif Değerlendirilmesi
ÖZKAN E., LAÇİN S., YAĞCI Ş. G., KÜÇÜK N. Ö.
19.Ulusal Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2007, vol.16, pp.38
2007
2007186. Kolorektal kanserde 18F FDG PET BT nin değeri
KÜÇÜK N. Ö., ÖZKAN E., TOKMAK E., ARAS G.
Türkiye Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2007, vol.16, pp.7
2007
2007187. F 18 FDG PET BT de nsidental Rabdomyosarkom Tanımlanan Rektal Karsinom Olgusu
ÖZKAN E., TOKMAK E., KÜÇÜK N. Ö.
19.Ulusal Nükleer Tıp Kongresi, Turkey, 25 - 29 April 2007, vol.16, pp.36
2003
2003188. PTCA ve veya CABG sonrasında restenozun değerlendirilmesinde myokard perfüzyon sintigrafisinin yeri Retrospektif analiz
KÜÇÜK N. Ö., ÖZKAN E., GÜLEV B., ARAS G.
Türkiye Nükleer Tıp Kongresi, Turkey, 10 - 14 May 2003, vol.12, pp.5
2003
2003189. Akut myokard infarktüsü sonrası Tl 201 reverse redistribüsyon
ÖZKAN E., ERBAY G., KÜÇÜK N. Ö., KIR K. M.
Türkiye Nükleer Tıp Kongresi, Turkey, 10 - 14 May 2003, vol.12, pp.10
2003
2003190. Nöroendokrin tümörlerde In 111 oktreotid sintigrafisi sonuçları
KÜÇÜK N. Ö., ÖZKAN E., ARAS G., SOYLU A.
Türkiye Nükleer tıp Kongresi, Turkey, 10 - 14 May 2003, vol.12, pp.127
2003
2003191. İyi diferansiye tiroid karsinomlu 388 hastada farklı dozlarda I 131 ile ablasyon oranı
KULAK H., KÜÇÜK N. Ö., KOPARAL H., UZUN B., ÖZKAN E., ARAS G.
Türkiye Nükleer Tıp Kongresi, Turkey, 10 - 14 May 2003, vol.12, pp.133
2003
2003192. Nöroblastomada kemik metastazlarının değerlendirilmesinde I 131 MIBG ve kemik sintigrafisinin yeri
KÜÇÜK N. Ö., UZUN B., ÖZKAN E., ARAS G., SOYLU A.
Türkiye Nükleer Tıp Kongresi, Turkey, 10 - 14 May 2003, vol.12, pp.128
2002
2002193. The assessment of reverse redistribution with Tc 99m MIBI GATED SPECT in acute myocardial infarction
ÖZKAN E., ERBAY G., KÜÇÜK N. Ö., KIR K. M.
Annual Congress of EANM, 31 August - 04 September 2002, vol.30, pp.58
2002
2002194. Use of lymphoscintigraphy and surgical gamma probe to determine the regional involvement in gastric cancer
KÜÇÜK N. Ö., ÖZMEN M. M., ZÜLFİKAROĞLU B., ARAS G., KOÇ M., SOYLU A., et al.
Annual Congress of EANM, 31 August - 04 September 2002, vol.29, pp.231
2002
2002195. Detection of sentinel nodes with lymphoscintigraphy and surgical gamma probe in four tongue cancer patients
KÜÇÜK N. Ö., ARICAN P., DEMİRELLER A., ARAS G., GÜLEV B., ÖZKAN E.
Türkiye Nükleer Tıp Kongresi, Turkey, 1 - 05 May 2002, vol.11, pp.33
2002
2002196. Tc 99m MIBI SPECT fort he evaluation of response to therapy in brain tumors Preliminary results
KÜÇÜK N. Ö., ANDRIEU M., GÜLEV B., ÖZKAN E., ARAS G., KIR K. M.
Türkiye Nükleer Tıp Kongresi, Turkey, 1 - 05 May 2002, vol.11, pp.47
Books
2023
20231. Plazma Hücre Hastalıklarında Nükleer Tıbbın Yeri
ÖZKAN E.
in: Plazma Hücre Hastalıkları, Meral BEKSAÇ, Editor, Medical Network, pp.90-94, 2023
2023
20232. Onkolojide Radyoimmünoterapi
ÖZKAN E., DEMİR B.
in: Nükleer Tıp ve Moleküler Görüntüleme, Mustafa Kibar, Editor, Akademisyen Kitabevi, pp.1485-1494, 2023
2022
20223. Radionuclide Therapy in benign thyroid diseases: Graves' disease
Araz M., Özkan E.
in: Radionuclide Therapy, Recep Bekiş,Berna Polack,Murat Fani Bozkurt, Editor, Springer, Basel, pp.83-95, 2022
2022
20224. Endokrinolojide Diğer Nükleer Görüntüleme ve Tedavi Yöntemleri
ARAZ M., ÖZKAN E.
in: Klinik Endokrinoloji, Bekir Uçan, Muhammed Kızılgül, Editor, Hipokrat Kitabevi, pp.685-697, 2022
2021
20215. Baş Boyun Kanserlerinde PET'İn Yeri ve Önemi
Araz M., Demir B., Özkan E.
in: Kulak Burun Boğaz Baş Boyun Cerrahisi, T.Metin Önerci,M.Hakan Korkmaz, Editor, Güneş Tıp Kitabevleri, Ankara, pp.71-82, 2021
2020
20206. Graves Hastalığında Radyonüklid Tedavi
ARAZ M., ÖZKAN E.
in: Radyonüklit Tedavi, Prof.Dr.Recep Bekiş, Prof.Dr.BErna Polack, Prof.Dr.Murat Fani Bozkurt, Editor, O’xxTıp Kitapevi, pp.94-113, 2020
2019
20197. A Patient with Differentiated Thyroid Cancer with Tg Values Constantly Above Normal but Not Increasing Gradually
Soydal Ç., Özkan E.
in: Thyroid and Parathyroid Diseases, Tamer Özülker,Mine Adaş,Semra Günay, Editor, Springer Nature, Zug, pp.287-290, 2019
2019
20198. A Patients with Papillary Thyroid Carcinoma and Biochemical Incomplete Response with Gradually Increasing Tg Values and Negative Imaging Studies
Soydal Ç., Özkan E.
in: Thyroid and Parathyroid Diseases, Tamer Özülker,Mine Adaş,Semra Günay, Editor, Springer Nature, Zug, pp.291-295, 2019
2019
20199. Follucular Thyroid Cancer and Bone Metastasis
Özkan E., Soydal Ç.
in: Thyroid and Parathyroid Diseases, Tamer Özülker,Mine Adaş,Semra Günay, Editor, Springer Nature, Zug, pp.317-321, 2019
2019
201910. Hurthle Cell Carcinoma
Özkan E., Soydal Ç.
in: Thyroid and Parathyroid Diseases, Tamer Özülker,Mine Adaş,Semra Günay, Editor, Springer Nature, Zug, pp.399-402, 2019
2019
201911. Differentiated Thyroid Cancer and Pulmonary Metastasis
Soydal Ç., Özkan E.
in: Thyroid and Parathyroid Diseases, TAmer Özülker,Mine Adaş,Semra Günay, Editor, Springer Nature, Zug, pp.331-334, 2019
2019
201912. Minimally Invasive Follicular Carcinoma
Özkan E., Soydal Ç.
in: Thyroid and Parathyroid Diseases, Tamer Özülker,Mine Adaş,Semra Günay, Editor, Springer Nature, Zug, pp.313-316, 2019
2019
201913. A Child with Papillary Thyroid Carcinoma: Role of Radioactive Iodine Therapy in Pediatric Patients
Soydal Ç., Özkan E.
in: Thyroid and Parathyroid Diseases, Tamer Özülker,Mine Adaş,Semra Günay, Editor, Springer Nature, Zug, pp.415-418, 2019
2018
201814. Karaciğer tümörlerinde intraarteriyel Y-90 mikroküre tedavi uygulamaları, yan etkileri ve hasta takibi
ÖZKAN E., SOYDAL Ç.
in: Primer ve Metastatik Karaciğer Tümörlerinde Radyonüklid Tedavi, Hikmet Akgül, Editor, Türkiye Klinikleri (Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.), pp.23-25, 2018
2018
201815. Differentiated Thyroid Cancer and Pulmonary Metastasis
SOYDAL Ç., ÖZKAN E.
in: Thyroid and Parathyroid Diseases, TAmer Özülker, Mine Adaş, Semra Günay, Editor, Sprenger, pp.331-334, 2018
2017
201716. Radyonuclide pain palliation treatment and radiosynovectomy
Özkan E.
in: Radionuclide Treatments, Doç.Dr.Çiğdem SOYDAL, Editor, INTECH, Rijeka, pp.1-2, 2017
2016
201617. Tanı ve Tedavide İyotun Kullanımı
Özkan E., Küçük N. Ö.
in: Her Yönü ile İyot, SELİM KURTOĞLU,FAHRİ BAYRAM, Editor, M Grup Matbaacılık , Ankara, pp.1-2, 2016
2015
201518. Gastric Carcinoma-II
KIR K. M., ÖZKAN E.
in: Nuclear Oncology, AKTOLUN CUMALİ, GOLDSMITH STANLEY J., Editor, Wolters Kluwer, Philadelphia, pp.92-100, 2015
2013
201319. Nükleer Tıp
Özkan E., Küçük N. Ö.
in: Klinik Onkoloji El Kitabı, YALÇIN B, Editor, Günertıp Kitabevi , Ankara, pp.1, 2013
2011
201120. Meme Kanserinde Nükleer Tıp Uygulamaları
Özkan E., Küçük N. Ö.
in: Meme Kanseri, AYDIN SÜHA,AKÇA TAMER, Editor, Nobel Tıp Kitapevi, Ankara, pp.1-2, 2011
2009
200921. Ürolojik Tümörlerde PET'in Güncel Yeri
Küçük N. Ö., Özkan E.
in: Ürolojide Yeni Ufuklar Üroonkoloji, BALTACI SÜMER, Editor, Güneştıp Kitabevi, Ankara, pp.1-2, 2009
Peer Reviews in Scientific Publications
December 2025
December 2025Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
December 2025
December 2025Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
November 2025
November 2025Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
November 2025
November 2025Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
August 2025
August 2025Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
July 2025
July 2025CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Journal Indexed in SCI-E
April 2025
April 2025Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
March 2025
March 2025NUCLEAR MEDICINE COMMUNICATIONS
Journal Indexed in SCI-E
February 2025
February 2025FRONTIERS IN ENDOCRINOLOGY
Journal Indexed in SCI-E
February 2025
February 2025EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Journal Indexed in SCI-E
March 2024
March 2024Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
February 2024
February 2024FRONTIERS IN PSYCHIATRY
Journal Indexed in SCI-E
February 2024
February 2024Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
December 2023
December 2023NUCLEAR MEDICINE COMMUNICATIONS
Journal Indexed in SCI-E
December 2023
December 2023Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
December 2023
December 2023NUCLEAR MEDICINE COMMUNICATIONS
Journal Indexed in SCI-E
September 2023
September 2023Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
May 2023
May 2023Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
April 2023
April 2023NUCLEAR MEDICINE COMMUNICATIONS
Journal Indexed in SCI-E
March 2023
March 2023IMMUNOTHERAPY
Journal Indexed in SCI-E
February 2023
February 2023Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
November 2022
November 2022Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
October 2022
October 2022Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
September 2022
September 2022NUCLEAR MEDICINE COMMUNICATIONS
National Scientific Refreed Journal
June 2022
June 2022Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
October 2021
October 2021JOURNAL OF HEALTH SCIENCE AND MEDICAL RESEARCH (JHSMR)
Other Indexed Journal
September 2021
September 2021Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
April 2021
April 2021Cancer Biotherapy and Radiopharmaceuticals
Journal Indexed in SCI-E
March 2021
March 2021Molecular Imaging and Radionuclide Therapy
National Scientific Refreed Journal
March 2021
March 2021Turkish Journal of Endocrinology and Metabolism
Journal Indexed in ESCI
February 2020
February 2020TURKISH JOURNAL OF MEDICAL SCIENCES
Journal Indexed in SCI-E
August 2018
August 2018TURKISH JOURNAL OF MEDICAL SCIENCES
Journal Indexed in SCI-E
August 2018
August 2018TURKISH JOURNAL OF MEDICAL SCIENCES
Journal Indexed in SCI-E
April 2018
April 2018BMJ CASE REPORTS
Journal Indexed in ESCI
March 2018
March 2018TURKISH JOURNAL OF MEDICAL SCIENCES
Journal Indexed in SCI-E
March 2018
March 2018GULHANE MEDICAL JOURNAL
National Scientific Refreed Journal
November 2017
November 2017Frontiers in Oncology
Journal Indexed in SCI-E
August 2017
August 2017GULHANE MEDICAL JOURNAL
National Scientific Refreed Journal
July 2017
July 2017EUROPEAN THYROID JOURNAL
Journal Indexed in SCI-E
May 2017
May 2017WORLD JOURNAL OF SURGICAL ONCOLOGY
Journal Indexed in SCI-E
May 2017
May 2017Kafkas Tıp Bilimleri Dergisi
National Scientific Refreed Journal
April 2017
April 2017ENDOCRINE RESEARCH
Journal Indexed in SCI-E
January 2017
January 2017CLINICAL OTOLARYNGOLOGY
Journal Indexed in SCI-E
December 2016
December 2016Türkiye Klinikleri Journal of Case Reports
National Scientific Refreed Journal
August 2016
August 2016FRONTIERS IN ONCOLOGY
Journal Indexed in SCI-E
May 2016
May 2016Kafkas Tıp Bilimleri Dergisi
National Scientific Refreed Journal
January 2016
January 2016JOURNAL OF MEDICAL ECONOMICS
Journal Indexed in SCI-E
April 2015
April 2015JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE
Journal Indexed in ESCI
February 2015
February 2015JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE
Journal Indexed in ESCI
October 2014
October 2014Genel Tıp Dergisi
National Scientific Refreed Journal
June 2014
June 2014Online Türk Sağlık Bilimleri Dergisi
National Scientific Refreed Journal